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Summary 
This is the sixth national monitoring report for the BreastScreen Australia Program. The 
report presents statistics on BreastScreen Australia screening activity and outcomes for 2001–
2002. A reporting interval of two years is used because it corresponds with the 
recommended interval between screens for asymptomatic women in the target age group of 
50–69 years.  
Participation 
• A total of 1,611,262 women participated in BreastScreen Australia screening in  
2001–2002. Of these women, 1,102,227 (68%) were in the screening program target age 
group of 50–69 years. 
• The proportion of women in the target population participating in the BreastScreen 
Australia Program has been steadily increasing, from 52.3% in 1996–1997 to 57.1% in 
2001–2002. 
• Although there was some variation in participation rates among different socioeconomic 
groups in the target population, the difference between the most and the least 
disadvantaged groups was only marginally significant, and all groups had participation 
rates above 55%.  
• The participation rates for Indigenous women and women from a non-English speaking 
background in the target population, 34.8% and 47.4% respectively, were significantly 
lower than the national rate of 57.1%.  
Detection of cancer 
• In order to reduce morbidity and mortality resulting from breast cancer, BreastScreen 
Australia aims to maximise the early detection of small-diameter (15 mm or less) 
invasive breast cancers. In 2002, 63% of all invasive breast cancers detected by 
BreastScreen Australia were small-diameter cancers. This proportion reduced to 54.0% 
for women who were attending for their first screen and increased to 65.8% for women 
who had previously been screened. 
• For women in the target age group, the age-standardised rate of small-diameter invasive 
cancer detection was 29.1 per 10,000 women screened in 2002. This was not significantly 
different from the 2001 rate of 29.0 per 10,000 women screened. 
• Data on interval cancers (that is, an invasive cancer detected between two screening 
rounds) were not available for New South Wales for 24-month follow-up. For other 
jurisdictions, the age-standardised rates of interval cancer for women in the target age 
group in the 24 months after their first screen ranged from 7.0 per 10,000 women-years 
in the Northern Territory to 15.6 per 10,000 women-years in Tasmania. 
• ‘Program sensitivity’ is the proportion of invasive breast cancers that are detected within 
the BreastScreen Australia Program out of all invasive breast cancers (interval cancers 
plus screen-detected cancers) diagnosed in Program-screened women in the screening 
interval. The Program sensitivity rate for women in the target age group in the 24 
months after their first screen ranged from 69.1% in Tasmania to 85.1% in Western 
Australia. 
• In 2002, 849 cases of ductal carcinoma in situ (see page 26) were detected in women 
participating in the BreastScreen Australia Program. The age-standardised detection rate 
  xiv 
 
 
 
for this condition was 10.5 per 10,000 women screened for women in the target age 
group and 10.0 per 10,000 women screened for all women aged 40 and over. 
Recall for assessment 
• In 2002, the proportion of women recalled for assessment because of an abnormal 
mammogram result was significantly higher for women being screened for the first time 
compared with women who had previously been screened. While 8.7% of women 
attending their first round of screening were recalled for further testing, only 4.2% of 
women attending for a subsequent round of screening were recalled.  
Rescreening 
• The proportion of women attending a BreastScreen Australia service in 2000 and 
returning for rescreening within the recommended 27-month interval increased with the 
number of previous screens. The age-standardised national rescreen rate for women 
attending a BreastScreen Australia service in 2000 for the first time was 61.8%. The 
rescreen rate increased to 72.0% for women attending for their second screen and 80.6% 
for women attending for a third or subsequent screen. 
Breast cancer incidence 
• With some fluctuations, there was a notable increase between 1987 and 2001 in the age-
standardised breast cancer incidence rates for women in the target age group. Incidence 
increased in the target age group from 196.9 new cancers per 100,000 women in 1987 to 
305.4 per 100,000 women in 2001.  
• Of the 11,791 new cases of breast cancer in 2001, 5,802 (49%) occurred in women in the 
target age group. Only 6% of cases were women aged under 40 years. Age-specific 
incidence rates in 2001 ranged from 123.1 new cancers per 100,000 women in the  
40–44 age group to 352.7 new cases per 100,000 women in the 60–64 age group. 
• Between 1996 and 2001, the national age-standardised incidence rate of ductal 
carcinoma in situ for women aged 50–69 years was 37.5 per 100,000 women. Across 
states and territories, the rate ranged from 17.4 cases per 100,000 women in the Northern 
Territory to 50.0 cases per 100,000 women in Western Australia. 
Breast cancer mortality 
• From 1993 onwards, a steady decline is evident in the age-standardised mortality rates 
for women in the target age group. The mortality rate for these women was 68.3 deaths 
per 100,000 women in 1988; in 2002, the corresponding figure was 56.7. A similar pattern 
of decline in mortality rates can be observed in women aged 70 and over. Mortality rates 
for women aged under 50 years remained the lowest and most consistent, staying below 
8 deaths per 100,000 women for the period 1987 to 2002. 
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Indicator 1: Participation 
Participation rate 
The participation rate is the percentage of women in the population screened through the 
BreastScreen Australia Program in a 24-month period by 5-year age groups (40–44, 45–49, 
50–54, 55–59, 60–64, 65–69, 70–74, 75–79, 80–84, 85+ years) and for the target age group  
(50–69 years). 
The participation indicator 
The participation rate is a population-based indicator that measures the proportion of the 
eligible population attending the screening program within the recommended screening 
interval. All women who are Australian citizens and those with permanent residency status 
are eligible for breast screening. It is important that a high proportion of women in the target 
age group attend for screening if BreastScreen Australia is to realise the anticipated 
reductions in overall mortality from breast cancer (DHSH 1994). The participation rate is a 
direct measure of this attendance. The indicator also provides information to assist in 
assessing the effectiveness of the program’s communication and education strategies, and 
can be used to assess whether the target age group is well represented in the screening 
population.  
The focus of this report is on women who have had a mammogram in the BreastScreen 
Australia Program. However, other mammography for screening and diagnosis (that is, 
investigating breast symptoms) is conducted outside the program. To some extent, therefore, 
the results presented in this report are an underestimation of screening on a national basis. 
This chapter reports on the participation rates for the BreastScreen Australia Program for 
2001 and 2002.  
One of the objectives of the BreastScreen Australia Program is ‘To achieve, after five years, a 
70 per cent participation in the National Program by women in the target group (50–69)…’ 
(BSANAC & DHAC 2000). The age-standardised national participation rate for women in the 
target group in 2001–2002 was 57.1%. This rate has been steadily increasing since  
1996–1997, when it was 52.3%. 
Age-standardised participation rates for women in the target age group (50–69 years), Australia, 
1996–1997 to 2001–2002 
 Objective(a) 1996–1997 1997–1998 1998–1999 1999–2000 2000–2001 2001–2002
Rate (%) 70.0 52.3 54.3 55.6 55.9 56.9 57.1
95% CI . . 52.1–52.3 54.1–54.4 55.5–55.8 55.8–56.0 56.8–57.0 57.0–57.2
(a) Performance objective of the BreastScreen Australia Program as set out in the National Accreditation Standards (NQMC unpublished). 
. .  Not applicable.  
Note: Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
Source: AIHW analysis of BreastScreen Australia data. 
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Another BreastScreen Australia objective relating to participation is ‘To achieve patterns of 
participation in the Program which are representative of the socioeconomic, ethnic and 
cultural profiles of the target population’ (BSANAC & DHAC 2000). This chapter reports 
national participation rates by region, socioeconomic status, Indigenous status and main 
language spoken at home. Below are some key points on each of these variables. 
Region 
Participation rates in ‘Major cities’ and ‘Very remote’ areas were significantly lower than 
those in other regions.  
The lower participation rates in ‘Major cities’ may reflect greater access to, and use of, 
private radiology services. Or there may be a group of women in the target age group who 
are working women and cannot easily access BreastScreen Australia services. For some 
women, proximity to services could create over-familiarity and lead to postponement of 
screening in order to accommodate other priorities.  
Lower rates in ‘Very remote’ areas may reflect a larger proportion of Indigenous women in 
the target age group who may not find services culturally accessible. The lower rates may 
also reflect the unavailability of BreastSceen Australia services in some remote areas of the 
Northern Territory. However, there are no data to test these hypotheses. Participation in 
rural areas is encouraged through the use of mobile mammography units. 
Socioeconomic status 
Breast cancer incidence and mortality are highest among women with the highest 
socioeconomic status (Tracey et al. 2004; Dunn et al. 2002). There was some variation in the 
participation rates among different socioeconomic groups, but there was only a marginally 
significant difference between the most and the least disadvantaged groups. This 
demonstrates the success of the program in reaching women at all socioeconomic levels, 
since there is no decline in participation with decreasing socioeconomic status.  
Indigenous status and main language spoken at home 
Participation among Indigenous women was significantly lower than that of non-Indigenous 
women. Similarly, participation among women who speak a language other than English at 
home was significantly lower than that of women who speak English at home. These results 
should, however, be treated with caution because of the data issues discussed in the report.  
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Participation of women aged 50–69 years in BreastScreen Australia, 
2001–2002 
 
Australia NSW Vic Qld WA SA Tas ACT NT
0
10
20
30
40
50
60
70
Participation per cent
 
Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 57.1 53.0* 59.4* 58.9* 55.3* 64.9* 59.1* 59.2* 44.7*
95% CI 57.0–57.2 52.8–53.2 59.2–59.6 58.6–59.1 55.0–55.7 64.5–65.3 58.5–59.8 58.3–60.1 43.5–45.9
* Significantly different from the all-Australia rate. 
Notes 
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
2. Period covers 1 January 2001 to 31 December 2002. 
• Of the 1,611,262 women screened during 2001 and 2002 as part of the BreastScreen 
Australia Program, 1,102,227 (68%) were in the target age group (50–69 years). 
• In 2001–2002, 57.1% (age-standardised) of women in the target age group attended a 
BreastScreen Australia service. The corresponding participation rate for all women aged 
40 and over was 37.5%. 
• Across states and territories, the age-standardised participation rate for women in the 
target age group ranged from 44.7% in the Northern Territory to 64.9% in South 
Australia. It should be noted that BreastScreen Australia services are not provided in 
some remote areas of the Northern Territory and this may lower the participation rate for 
this jurisdiction.  
 
For more information, see: 
Tables 1 and 2 
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Participation of women aged 50–69 years in BreastScreen Australia, 
2000–2001 and 2001–2002 
 
Australia NSW Vic Qld WA SA Tas ACT NT
0
10
20
30
40
50
60
70
80
Participation per cent
2000–2001
2001–2002
 
Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
2000–2001 56.9 53.0 59.2 58.4 55.4 64.3 60.0 57.0 46.3
95% CI 56.8–57.0 52.9–53.2 59.0–59.4 58.1–58.6 55.1–55.7 63.9–64.7 59.3–60.6 56.0–57.8 45.1–47.5
2001–2002 57.1 53.0 59.4 58.9 55.3 64.9 59.1 59.2* 44.7
95% CI 57.0–57.2 52.8–53.2 59.2–59.6 58.6–59.1 55.0–55.7 64.5–65.3 58.5–59.8 58.3–60.1 43.5–45.9
* Significantly different from the 2000–2001 rate. 
Notes 
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
2. Periods cover 1 January 2000 to 31 December 2001 and 1 January 2001 to 31 December 2002. 
• Participation in BreastScreen Australia among women in the target age group rose from 
56.9% (age-standardised) in 2000–2001 to 57.1% in 2001–2002. However, this difference 
was not significant. 
• The Australian Capital Territory was the only jurisdiction to show a significant increase 
in participation for women in the target age group in 2001–2002. In the Australian 
Capital Territory, the age-standardised participation rate rose from 57.0% in 2000–2001 to 
59.2% in 2001–2002. 
 
For more information, see: 
Tables 1 and 2 
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Participation of women aged 50–69 years in BreastScreen Australia 
by region, 2001–2002 
 
Australia Major cities Inner regional Outer regional Remote Very remote
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia Major cities Inner regional Outer regional Remote Very remote
Rate (%) 57.1 55.6* 59.7* 60.7* 60.9* 47.9*
95% CI 57.0–57.2 55.5–55.7 59.5–60.0 60.3–61.0 59.9–61.8 46.6–49.2
* Significantly different from the all-Australia rate. 
Notes  
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
2. Period covers 1 January 2001 to 31 December 2002. 
3. The Australian Standard Geographical Classification (ASGC) was used to create the above categories (ABS 2001). 
• Participation in BreastScreen Australia varied significantly between regions in  
2001–2002.  
• Age-standardised participation rates for women in the target age group in ‘Major cities’ 
(55.6%) and ‘Very remote’ areas (47.9%) were significantly lower than the national rate of 
57.1%. Significantly higher than the national rate were ‘Inner regional’ areas at 59.7%, 
‘Outer regional’ areas at 60.7% and ‘Remote’ areas at 60.9%. 
For more information, see: 
Table 3 
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Participation of women aged 50–69 years in BreastScreen Australia 
by socioeconomic status, 2001–2002 
 
Australia 1st - high SES 2nd 3rd 4th 5th - low SES
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Quintile  
Notes 
1.  Bars on columns represent 95% confidence intervals.  
2.  SES means socioeconomic status (see details in Appendix A). 
Source: AIHW analysis of BreastScreen Australia data.  
 
 Australia 1st quintile 2nd quintile 3rd quintile 4th quintile 5th quintile
Rate (%) 57.1 57.0 55.9* 58.4* 58.4* 55.7*
95% CI 57.0–57.2 56.7–57.2 55.6–56.1 58.2–58.6 58.1–58.6 55.5–56.0
* Significantly different from the all-Australia rate. 
Notes  
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
2. Period covers 1 January 2001 to 31 December 2002. 
3. The first quintile corresponds to the highest socioeconomic status and the fifth to the lowest socioeconomic status. 
• Women in the target age group living in postcodes with the lowest socioeconomic status 
had the lowest age-standardised participation rate (55.7%) in 2001–2002. The 
socioeconomic groups with the highest participation rates were the third and fourth 
quintiles, both 58.4%.  
• The participation rate for women living in postcodes with the highest socioeconomic 
status (57.0%) was significantly higher than women in the lowest socioeconomic group. 
 
For more information, see: 
Table 4 
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Participation of women aged 50–69 years in BreastScreen Australia 
by Indigenous status, 2001–2002 
 
Australia Indigenous Non-Indigenous
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia Indigenous Non-Indigenous
Rate (%) 57.1 34.8* 53.9
95% CI 57.0–57.2 34.0–35.6 53.8–54.0
* Significantly different from the non-Indigenous rate. 
Notes  
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
2. Period covers 1 January 2001 to 31 December 2002. 
3. Women whose Indigenous status was recorded as ‘not stated’ were included in the analysis for all women but excluded from the analysis by 
Indigenous status. 
• At the 2001 national population Census, 1.1% of the female population aged 50–69 years 
were Aboriginal and Torres Strait Islander people. 
• Of the 1,611,262 women aged 40 and over participating in screening through the 
BreastScreen Australia Program in 2001–2002, there were 11,542 (0.7%) who identified 
themselves as Indigenous. While 85,037 women were classified as not stating their 
Indigenous status, the true figure is higher because some jurisdictions classified these 
women as ‘non-Indigenous’ (see Appendix A for coding of Indigenous status). The 
comparison of participation rates between Indigenous and non-Indigenous women 
should therefore be treated with caution. 
• The age-standardised participation rate for Indigenous women (34.8%) was significantly 
lower than both the non-Indigenous rate (53.9%) and the national rate (57.1%). 
For more information, see: 
Table 5 
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Participation of women aged 50–69 years in BreastScreen Australia 
by language spoken at home, 2001–2002 
 
Australia English speaking Non-English speaking
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia English speaking Non-English speaking
Rate (%) 57.1 58.9* 47.4*
95% CI 57.0–57.2 58.8–59.0 47.2–47.7
* Significantly different from the all-Australia rate. 
Notes  
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
2. Period covers 1 January 2001 to 31 December 2002. 
3. Women who were recorded as not stating their language spoken at home are included in the analysis for all women but excluded from the 
analysis by language. 
• Of the 1,611,262 women aged 40 and over participating in screening through the 
BreastScreen Australia Program in 2001–2002, there were 214,986 (13%) who identified as 
non-English speaking. While 3,944 women were classified as not stating the language 
they spoke at home, the true figure may be higher as some jurisdictions did not use the 
‘not stated’ category. Women in these jurisdictions who did not state the language they 
spoke at home were allocated to one of the other two categories (Appendix A). 
Participation rates between English speaking and non-English speaking women should 
therefore be treated with caution. 
• There was a significantly lower age-standardised participation rate for women in the 
target age group from a non-English speaking background (47.4%) than for English 
speaking women (58.9%). English speaking women had a significantly higher 
participation rate, at 58.9%, than the national rate of 57.1% (age-standardised). 
For more information, see: 
Table 6 
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Age distribution of women aged 40 years and over screened by  
BreastScreen Australia, 2001–2002 
 
40-49 50-69 70+
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Source: AIHW analysis of BreastScreen Australia data. 
 
Age 40–49 50–69 70+
% 17.9 68.4 13.7
Notes  
1. Rates are the number of women screened as a percentage of all women aged 40 or over screened by BreastScreen Australia. 
2. Period covers 1 January 2001 to 31 December 2002. 
• Two-thirds (64.4%) of women participating in the BreastScreen Australia Program in 
2001–2002 were in the target age group (50–69 years). Of all women screened, 17.9% were 
aged 40–49 years, and 13.7% were aged 70 years and over. 
 
 
 
 
 
 
 
 
For more information, see: 
Tables 1 and 2 
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Indicator 2: Detection of small 
invasive cancers  
Small invasive cancer detection rate  
The detection rate for small invasive cancers is the rate of women with small diameter  
(≤ 15 mm) invasive breast cancers per 10,000 women screened by five-year age groups  
(40–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, 80–84, 85+ years) and for the target 
age group (50–69 years). Detection rates for all invasive cancers are also provided by 
screening round (that is, first round and subsequent rounds), five-year age groups and for 
the target age group. 
The small invasive cancer detection indicator 
The small invasive cancer detection indicator measures the rate of women with invasive 
breast cancers that are 15 mm or less in size detected at a BreastScreen Australia service. This 
is expressed as the number of women with small cancers detected for every 10,000 women 
screened.  
A greater rate of detection of small cancers within the BreastScreen Australia Program 
increases the likelihood that the desired reductions in morbidity and mortality from breast 
cancer will be achieved. One of BreastScreen Australia’s aims is to maximise the early 
detection of breast cancers (BSANAC & DHAC 2000). Finding breast cancer early often 
means that the cancer is small, can be more effectively treated and is less likely to have 
spread to other parts of the body. As a result, women who have cancers detected early may 
suffer less morbidity from breast cancer (Day 1991). 
In 2002, 63% of all invasive breast cancers detected by BreastScreen Australia in women aged 
40 and over were small-diameter cancers.  
The table below shows the percentage of all invasive cancers detected that were small 
diameter invasive breast cancers, by screening round, for women screened in 2002. 
Percentage of invasive cancers detected that were small (≤ 15 mm) in diameter, 2002 
Age group First screening round Subsequent screening rounds
50–69 years 55.7 65.2
40 years and over 54.0 65.8
Source: AIHW analysis of BreastScreen Australia data. 
It is evident that a higher proportion of women attending the program for the first time have 
tumours larger than 15 mm compared with those who have been screened previously. This 
is because regular, biennial mammography provides the best chance for the detection of 
early-stage small cancers (AHMAC 1990).  
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Small (≤ 15mm) invasive breast cancer detection in women aged 
50–69, first screening round, 2002 
 
Aust NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 40.5 35.5 36.4 42.5 45.2 99.7* 24.0 38.0 50.3
95% CI 35.1–46.4 27.9–44.5 25.5–50.0 31.2–56.4 27.2–68.6 54.8–159.8 2.9–86.8 10.2–93.0 1.3–280.0
* Significantly different from the all-Australia rate. 
Note: Rates are the number of women with small invasive cancers detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 1998. 
• In 2002, small-diameter invasive cancers were found in 394 women aged 40 and over 
attending a BreastScreen Australia service for their first screen. Of these women, 256 
were in the target age group (50–69 years). The age-standardised detection rate was 40.5 
per 10,000 women screened for women in the target age group and 39.1 per 10,000 
women screened for all women aged 40 and over. 
• Across the states and territories, the age-standardised detection rate for small invasive 
cancers in women in the target age group ranged from 24.0 per 10,000 women screened 
in Tasmania to 99.7 per 10,000 women screened in South Australia. Large confidence 
intervals can be observed in the smaller states and territories due to the small number of 
cases detected in these jurisdictions. 
For more information, see: 
Tables 7 and 8 
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Small (≤ 15 mm) invasive breast cancer detection in women aged 
50–69, subsequent screening rounds, 2002 
 
 
Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 27.8 28.2 24.5 27.4 28.5 33.2 34.1 27.8 12.2
95% CI 26.3–29.3 25.6–31.0 21.9–27.4 24.3–30.9 23.9–33.8 28.2–38.7 25.3–44.8 17.7–41.6 2.3–36.0
Notes  
1. Rates are the number of women with small invasive cancers detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 1998. 
2. None of the rates was significantly different from the all-Australia rate. 
• In 2002, small-diameter invasive cancers were found in 1,963 women aged 40 and over 
attending a BreastScreen Australia service for their second or subsequent screen. Of these 
women, 1,408 were in the target age group (50–69 years). The age-standardised detection 
rate was 27.8 per 10,000 women screened for women in the target age and 26.2 for all 
women aged 40 and over. In both age categories, the small cancer detection rates for 
women attending their second or subsequent screen were significantly lower than the 
rates for women attending their first screen (tables 8 and 10). 
• The age-standardised detection rate of small invasive cancers by state and territory 
ranged from 12.2 per 10,000 women screened in the Northern Territory to 34.1 in 
Tasmania. However, this difference is not statistically significant. The large confidence 
intervals observed in the smaller states and territories are due to the small number of 
cases detected in these jurisdictions. 
For more information, see: 
Tables 9 and 10 
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Small (≤ 15 mm) invasive breast cancer detection in women aged 
50–69, all screening rounds, 2001 and 2002 
 
Aust NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
2001 rate 29.0 28.5 27.0 30.5 29.7 30.5 33.9 36.1 28.9
95% CI 27.7–30.4 26.0–30.9 24.3–29.7 27.1–33.9 25.0–34.3 26.0–35.3 24.1–43.7 23.8–50.2 8.3–53.5
2002 rate 29.1 29.1 25.6 29.1 31.2 35.7 33.1 30.1 14.6
95% CI 27.7–30.5 26.6–31.7 23.0–28.3 26.0–32.4 26.6–36.3 30.7–41.2 24.8–43.3 20.0–43.5 3.6–38.1
Notes  
1. Rates are the number of women with small invasive cancers detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 1998. 
2. None of the 2002 rates was significantly different from the 2001 rates. 
• There was no significant change in the detection rate of small invasive cancers from 2001 
to 2002. The national age-standardised detection rate was 29.0 per 10,000 women 
screened in 2001 and 29.1 per 10,000 women screened in 2002. 
• In 2002, small invasive cancers were detected in 2,357 women. Of these women, 1,664 
(71%) were in the target age group. Small invasive cancers made up 64% of all cancers 
detected in 2002. For women in the target age group, the proportion of small invasive 
cancers out of all cancers was also 64%. 
For more information, see: 
Tables 7, 8, 9, 10, 11 and 12 
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Small (≤ 15mm) invasive breast cancer detection by age, 2002 
 
40-44 45-49 50-54 55-59 60-64 65-69 70+
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Source: AIHW analysis of BreastScreen Australia data. 
 
Age-specific rate 40–44 45–49 50–54 55–59 60–64 65–69 70+
First screening round 11.9 16.7 25.0 32.3 53.1 62.8 70.5
Subsequent screening rounds 7.6 14.1 18.1 27.8 31.8 39.2 42.0
Note: Rates are the number of women with small invasive cancers detected per 10,000 women screened. 
•  The steady increase in the detection of small (≤ 15 mm diameter) invasive cancers with 
age reflects the greater incidence of breast cancer with age (Table 43). The detection rate 
for women aged 40–44 years making a first round attendance at a BreastScreen Australia 
service in 2002 was 11.9 per 10,000 women screened. This rate increased to 70.5 per 
10,000 women screened for women aged 70 and over. A similar pattern occurred for 
women making a second or subsequent round attendance, although the rate of increase 
with age was not as great. 
 
 
 
 
 
 
 
For more information, see: 
Tables 8, 10 and 43 
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All-size invasive breast cancer detection in women aged  
50–69 years, first screening round, 2002 
 
Aust NSW Vic Qld WA SA Tas ACT NT
0
50
100
150
200
250
Per 10,000 women screened
 
Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 72.2 64.4 71.7 71.2 81.6 137.5* 67.1 49.5 60.4
95% CI 65.0–80.0 54.1–76.0 56.0–89.8 56.2–88.9 56.7–112.1 87.0–200.6 25.8–140.5 15.8–112.1 0.0–249.9
* Significantly different from the all-Australia rate. 
Note: Rates are the number of women with invasive cancers detected per 10,000 women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998.  
• In 2002, the age-standardised invasive cancer detection rate for women attending a 
BreastScreen Australia Service for the first time was 72.2 per 10,000 women screened. 
Across the states and territories, the Australian Capital Territory had the lowest age-
standardised detection rate, at 49.5 per 10,000 women screened, and South Australia had 
the highest rate, at 137.5 per 10,000 women screened. 
• The invasive cancer detection rate for all women aged 40 and over (70.6 per 10,000 
women screened) was not significantly different from the rate for women in the target 
age group (72.2 per 10,000 women screened). 
 
 
 
 
For more information, see: 
Tables 13 and 14 
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All-size invasive breast cancer detection in women aged  
50–69 years, subsequent screening rounds, 2002 
 
 
Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 42.7 43.1 36.9* 44.9 44.2 50.0 47.9 39.5 20.4
95% CI 40.9–44.5 39.9–46.5 33.7–40.4 40.9–49.3 38.3–50.7 43.9–56.7 37.4–60.5 27.2–55.5 4.5–54.5
* Significantly different from the all-Australia rate. 
Notes: Rates are the number of women with invasive cancers detected per 10,000 women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
•   In 2002, the age-standardised invasive cancer detection rate for women in the target age 
group attending a BreastScreen Australia service for their second or subsequent screen 
was 42.7 per 10,000 women screened. This is significantly lower than the detection rate 
for first round attendances (72.2 per 10,000 women screened). 
•  The age-standardised invasive cancer detection rate for all women aged 40 and over, 
attending for their second or subsequent screen, was 40.1 per 10,000 women screened. 
This is not significantly different from the rate for women in the target group (42.7 per 
10,000 women screened). 
•  Across the states and territories, the age-standardised invasive cancer detection rate for 
women in the target age group ranged from 20.4 per 10,000 women screened in the 
Northern Territory to 50.0 per 10,000 women screened in South Australia. 
  
For more information, see: 
Tables 15 and 16 
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Indicator 3: Sensitivity 
3a. Interval cancer rate 
The interval cancer rate is the rate of invasive breast cancers detected during an interval 
between two screening rounds per 10,000 women-years. It is stratified by 10-year age groups 
(40–49, 50–59, 60–69, 70+ years), time since screen (0–12 months, 13–24 months, and  
0–24 months) and screening round (first or subsequent).  
3b. Program sensitivity 
The program sensitivity rate is the percentage of women with screen-detected invasive 
breast cancer among all Program-screened women diagnosed with invasive breast cancer 
during the screening interval (screen-detected and interval cancers). It is stratified by 10-year 
age groups (40–49, 50–59, 60–69, 70+ years), time since screen (0–12 months, 0–24 months) 
and screening round (first or subsequent).  
The sensitivity indicator 
An interval cancer is an invasive breast cancer that is diagnosed after a screening episode 
that detected no cancer and before the next scheduled screening episode. The interval cancer 
rate is expressed per 10,000 women-years at risk (see the glossary for definitions of ‘women-
years at risk’ and ‘interval cancer’). It measures how effective the BreastScreen Australia 
Program is at detecting the presence of breast cancer in well women. A low interval cancer 
rate is one measure of the effectiveness of the screening process.  
Program sensitivity measures the ability of the Program to detect invasive breast cancers in 
women attending for screening. The Program needs to achieve a high sensitivity in order to 
be effective. Program sensitivity is the proportion of invasive breast cancers that are detected 
within the BreastScreen Australia Program out of all invasive breast cancers (interval cancers 
plus screen-detected cancers) diagnosed in Program-screened women in the screening 
interval.  
In this chapter data for the years 1998, 1999 and 2000 are combined. This aggregation 
improves the stability of rates, especially those of the small states and territories. 
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Interval cancer rate for women aged 50–69 years, screened during 
years 1998, 1999 and 2000, first screening round, 0–12 months 
follow-up 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 7.1 6.7 6.8 7.0 5.6 8.8 11.8 7.8 5.6
95% CI 6.1–8.2 5.1–8.7 4.8–9.3 5.2–9.2 2.4–11.0 5.1–13.9 4.0–26.3 0.2–30.4 0.7–20.1
Notes  
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
2. The data include both symptomatic and asymptomatic women. 
3. None of the rates was significantly different from the all-Australia rate. 
• The age-standardised interval cancer rate for women in the target age group  
0–12 months after their first screen was 7.1%. 
• Across the states and territories, the age-standardised rates of interval cancer ranged 
from 5.6 per 10,000 women-years in the Northern Territory and Western Australia to 11.8 
per 10,000 women-years in Tasmania. 
 
 
For more information, see: 
Table 17 
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Interval cancer rate for women aged 50–69 years, screened during 
years 1998, 1999 and 2000, first screening round, 0–24 months 
follow-up 
 
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate n.a. n.a. 11.2 11.3 8.1 10.6 15.6 13.0 7.0
95% CI n.a. n.a. 9.2–13.5 9.6–13.2 5.1–12.1 7.6–14.3 8.6–25.8 5.0–26.3 2.3–16.4
n.a.  Not available 
Notes  
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
2. The data include both symptomatic and asymptomatic women. 
3. New South Wales data were unavailable at the time of publication. 
• Across the states and territories with data available, the age-standardised rates of 
interval cancer for women in the target age group (50–69 years) 0–24 months after their 
first screen ranged from 7.0 per 10,000 women-years in the Northern Territory to 15.6 per 
10,000 women-years in Tasmania. 
 
 
 
For more information, see: 
Table 19 
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Interval cancer rate for women aged 50–69 years, screened during 
years 1998, 1999 and 2000, subsequent screening round,  
0–12 months follow-up 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 7.9 7.8 7.6 8.0 6.6 8.0 8.0 18.1* 4.6
95% CI 7.4–8.4 7.0–8.7 6.7–8.6 6.8–9.4 5.3–8.3 6.4–9.8 5.4–11.4 12.7–25.0 0.4–17.1
* Significantly different from the all-Australia rate. 
Notes  
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
2. The data include both symptomatic and asymptomatic women. 
•  The age-standardised interval cancer rate for women in the target age group  
0–12 months after their second or subsequent screen was 7.9%. 
•  Across the states and territories, the age-standardised rates of interval cancer ranged 
from 4.6 per 10,000 women-years in the Northern Territory to 18.1 per 10,000 women-
years in the Australian Capital Territory. 
 
 
 
For more information, see: 
Table 20 
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Interval cancer rate for women aged 50–69 years, screened during 
years 1998, 1999 and 2000, subsequent screening round,  
0–24 months follow-up 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate n.a. n.a. 10.2 11.9 9.1 10.4 10.0 14.8 9.4
95% CI n.a. n.a. 9.5–11.1 10.9–13.0 7.9–10.5 9.1–11.8 7.8–12.6 11.3–19.0 4.0–18.2
n.a.  Not available. 
Notes  
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
2. The data include both symptomatic and asymptomatic women. 
3. New South Wales data were unavailable at the time of publication. 
•  Across the states and territories with data available, the age-standardised rates of 
interval cancer for women in the target age group (50–69 years) 0–24 months after their 
second or subsequent screen ranged from 9.1 per 10,000 women-years in Western 
Australia to 14.8 per 10,000 women-years in the Australian Capital Territory. 
 
 
 
 
For more information, see: 
Table 22 
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Program sensitivity for women aged 50–69 years, screened during 
years 1998, 1999 and 2000, first screening round, 0–12 months 
follow-up 
 
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 89.4 89.6 89.7 89.2 91.5 88.7 84.7 92.8 90.3
95% CI 86.1–92.9 83.7–96.0 82.0–97.9 83.3–95.5 77.9–100.0 77.2–100.0 64.7–100.0 63.6–100.0 44.1–100.0
Notes  
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-
standardised to the population of women attending a BreastScreen Australia service in 1998. 
2. The data include both symptomatic and asymptomatic women. 
3. None of the rates was significantly different from the all-Australia rate. 
• The age-standardised Program sensitivity rate for women in the target age group  
0–12 months after their first screen was 89.4%. 
• Across the states and territories, the Program sensitivity rate ranged from 84.7% in 
Tasmania to 92.8% in the Australian Capital Territory. 
 
 
 
 
For more information, see: 
Table 23 
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Program sensitivity for women aged 50–69 years, screened during 
years 1998, 1999 and 2000, first screening round, 0–24 months 
follow-up 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) n.a. n.a. 73.9 72.7 85.1 77.3 69.1 81.2 80.5
95% CI n.a. n.a. 67.3–81.0 67.6–78.1 72.2–100.0 66.4–89.6 52.2–91.0 54.9–100.0 34.4–100.0
n.a.  Not available. 
Notes  
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-
standardised to the population of women attending a BreastScreen Australia service in 1998. 
2. The data include both symptomatic and asymptomatic women. 
3. New South Wales data were unavailable at the time of publication. 
• Across the states and territories with data available, the Program sensitivity rate for 
women in the target age group 0–24 months after their first screen ranged from 69.1% in 
Tasmania to 85.1% in Western Australia. 
 
 
 
 
 
For more information, see: 
Table 24 
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Program sensitivity for women aged 50–69 years, screened during 
years 1998, 1999 and 2000, subsequent screening round,  
0–12 months follow-up 
 
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 83.2 82.2 83.7 83.2 86.3 84.1 82.2 72.6 90.2
95% CI 81.6–84.8 79.5–85.0 80.7–86.8 79.4–87.2 80.3–92.6 78.4–90.2 71.6–94.2 59.1–88.2 61.0–100.0
Notes  
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-
standardised to the population of women attending a BreastScreen Australia service in 1998. 
2. The data include both symptomatic and asymptomatic women. 
3. None of the rates was significantly different from the all-Australia rate. 
• The Program sensitivity rate for women in the target age group 0–12 months after their 
second or subsequent screen was 83.2%. 
• Across the states and territories, the Program sensitivity rate ranged from 72.6% in the 
Australian Capital Territory to 90.2% in the Northern Territory. 
 
 
For more information, see: 
Table 25 
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Program sensitivity for women aged 50–69 years, screened during 
years 1998, 1999 and 2000, subsequent screening round,  
0–24 months follow-up 
 
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) n.a. n.a. 65.9 63.4 80.5 67.8 69.2 81.3 90.2
95% CI n.a. n.a. 63.4–68.5 60.3–66.6 74.9–86.5 63.0–72.9 59.5–80.1 66.3–98.7 61.0–100.0
n.a.  Not available. 
Notes  
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-
standardised to the population of women attending a BreastScreen Australia service in 1998. 
2. The data include both symptomatic and asymptomatic women. 
3. New South Wales data were unavailable at the time of publication. 
• Across the states and territories with data available, the Program sensitivity rate for 
women in the target age group 0–24 months after their second or subsequent screen 
ranged from 63.4% in Queensland to 90.2% in the Northern Territory. 
 
For more information, see: 
Table 26 
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Indicator 4: Detection of ductal 
carcinoma in situ  
Ductal carcinoma in situ detection rate  
The ductal carcinoma in situ (DCIS) detection rate is the rate of women with DCIS per 10,000 
women screened by 10-year age groups (40–49, 50–59, 60–69, 70+ years) and for the target 
age group (50–69 years). 
The DCIS detection indicator 
The DCIS indicator measures the rate of DCIS diagnosed in women attending a BreastScreen 
Australia service. This is expressed as the number of women with DCIS detected for every 
10,000 women screened. DCIS is a disease that involves changes in the cells in the lining of 
the ducts of the breast. Although the changes are like those seen in breast cancer, DCIS has 
not spread beyond the ducts (NBCC et al. 2000). The natural history of DCIS is still not well 
understood, although women with the condition are at increased risk of subsequent 
development of invasive breast cancer (NQMC unpublished).  
DCIS is asymptomatic in the majority of cases and is usually detected as a change on a 
mammogram or as a chance finding on a breast biopsy for another condition. Before the 
introduction of nationwide mammographic screening in Australia in 1991, DCIS was rarely 
found. Since then, screening mammography has increased the detection rate for DCIS 
(NBCC et al. 2000). 
Early detection of high-grade DCIS through screening, and its subsequent treatment, is likely 
to prevent deaths from breast cancer (NQMC unpublished). The ability to detect DCIS can 
also be seen as an indicator of the quality of the screening process, since it reflects  
good-quality imaging and screen-film reading. 
In 2002, the national age-standardised rate of DCIS detection was 10.0 women with DCIS per 
10,000 women aged 40 and over. This is slightly lower than the detection rate for 2001, at 
10.5 per 10,000 women screened, but the difference is not statistically significant.  
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Ductal carcinoma in situ detection in women aged 50–69 years, 
2002 
 
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 10.5 9.8 9.3 9.8 17.7* 10.6 8.8 14.2 8.2
95% CI 9.7–11.4 8.4–11.3 7.8–11.0 8.0–11.8 14.3–21.6 8.0–13.8 4.8–14.8 7.7–24.0 1.7–24.0
* Significantly different from the all-Australia rate. 
Note: Rates are the number of cases of DCIS per 10,000 women screened and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
• DCIS was detected in 849 women participating in the BreastScreen Australia Program in 
2002, including 603 cases in women in the target age group. The age-standardised DCIS 
detection rate was 10.5 per 10,000 women screened for women in the target age group, 
and 10.0 per 10,000 women screened for all women aged 40 and over. 
• The age-standardised rate of DCIS detection for women in the target age group ranged 
from 8.2 per 10,000 women screened in the Northern Territory to 17.7 per 10,000 women 
screened in Western Australia. 
 
 
For more information, see: 
Tables 27 and 28 
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Indicator 5: Recall to assessment  
Recall to assessment rate 
The recall to assessment rate is the proportion of all women screened in the calendar year 
2002 who were recalled for assessment by five-year age groups (40–44, 45–49, 50–54, 55–59, 
60–64, 65–69, 70–74, 75–79, 80–84, and 85+ years) and for the target age group (50–69 years). 
The recall to assessment indicator 
The recall to assessment indicator measures the rate of women who are recalled for 
assessment following attendance for a routine screening at a BreastScreen Australia service. 
In most cases, the recall is made because a woman’s screening mammogram shows signs 
that there may be breast cancer. Women may also be recalled for other non-mammographic 
reasons. During assessment, a woman might undergo further tests, such as additional 
mammography, physical examination, ultrasound and, if required, a fine needle aspiration 
or a core biopsy.  
BreastScreen Australia aims to maximise the number of cancers detected—in particular, the 
number of small cancers—while minimising the number of unnecessary investigations. Most 
women recalled to assessment are found not to have breast cancer (BreastScreen SA 1999; 
BreastScreen Queensland 2000). 
Women attending the program for the first time have a higher all-size cancer detection rate 
than those who have previously been screened. This is reflected in a higher recall to 
assessment rate for women who attend for their first screening round compared with those 
who attend for a subsequent round. The table below shows recall to assessment rates by 
screening round for 2001 and 2002. 
Age-standardised recall to assessment rates for women aged 40 and over, 2001 and 2002 
 First screening round Subsequent screening rounds
2001 rate (%) 8.3 4.0
95% CI 8.1–8.5 4.0–4.1
2002 rate (%) 8.7 4.2
95% CI 8.5–8.9 4.1–4.2
Source: AIHW analysis of BreastScreen Australia data. 
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Recall to assessment rate for women aged 50–69 years, 
mammographic reasons, first screening round, 2002 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 8.9 8.6 8.5 9.7 10.3* 6.5* 12.1* 7.3 5.2*
95% CI 8.6–9.1 8.3–9.0 7.9–9.0 9.1–10.2 9.4–11.2 5.5–7.6 10.0–14.5 5.5–9.4 2.9–8.4
* Significantly different from the all-Australia rate. 
Note: Rates are the number of women recalled for assessment as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
• In 2002, 8.9% (age-standardised) of women in the target age group attending their first 
screen were recalled for assessment due to an abnormal mammogram result. 
• Age-standardised rates of recall for assessment for women in the target age group 
ranged from 5.2% in the Northern Territory to 12.1% in Tasmania. South Australia, at 
6.5%, and the Northern Territory, at 5.2%, both had recall rates significantly lower than 
the national rate. Western Australia, at 10.3%, and Tasmania, 12.1%, had recall rates 
significantly higher than the national rate. 
 
 
 
For more information, see: 
Tables 29 and 30 
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Recall to assessment rate for women aged 50–69 years, 
mammographic reasons, subsequent screening round, 2002 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 4.1 4.2 3.9 4.8* 3.8* 2.5* 5.3* 4.9* 3.5
95% CI 4.0–4.1 4.1–4.3 3.8–4.0 4.7–4.9 3.6–3.9 2.4–2.7 4.9–5.7 4.4–5.4 2.7–4.4
* Significantly different from the all-Australia rate. 
Note: Rates are the number of women recalled for assessment as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
• Of women in the target age group who were screened for a second or subsequent time in 
2002, 4.1% (age-standardised) were recalled for assessment due to an abnormal 
mammogram result. This is significantly lower than the rate for women attending for 
their first screen (Table 30). 
• Age-standardised rates of recall for assessment for women in the target age group 
screened for a second or subsequent time ranged from 2.5% in the South Australia to 
5.3% in Tasmania. 
 
 
 
 
 
For more information, see: 
Tables 31 and 32 
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Indicator 6: Rescreening 
Rescreen rate 
The rescreen rate is the proportion of all women screened in 2000 whose screening outcome 
was a recommendation to return for screening in two years who returned for a screen within 
27 months. This rate is reported by five-year age groups (40–44, 45–49, 50–54, 55–59, 60–64, 
65–69, 70–74, 75–79, 80–84, and 85+ years) and for the target age group (50–67 years). 
Although the BreastScreen Australia target age group is 50–69 years, only women aged  
50–67 years are reported for the rescreen indicator. This is because women aged 68–69 years 
in the index year were outside the target age group 27 months after their index screen and, 
therefore, were not expected to return for screening. 
The rescreen indicator 
The rescreen indicator measures the proportion of women who return for screening in the 
program within the recommended screening interval. The interval between screens is an 
important factor influencing the level of detection of cancers within the program. Intervals 
that are too long may allow tumours to grow to the point where symptoms become evident, 
thus eliminating the advantage of screening. A high rescreen rate is also important for 
maintaining the participation rate. The anticipated reductions in mortality can be achieved 
only if a high proportion of women in the target age group attend for screening every two 
years. By having a mammogram every two years, a woman can reduce her chance of dying 
from breast cancer by up to 40% (Duffy et al. 1991; Fletcher et al. 1993; Feig 1998). The 
recommended interval of 27 months includes an additional 3 months to allow for potential 
delays in screening availability. 
Women in the target age group are re-invited biennially. Some states and territories have a 
policy of re-inviting a proportion of women annually, for example, women with a strong 
family history of breast cancer. The data for this indicator include women who are 
recommended for annual screening as well as those screened biennially. 
The proportion of women who returned for screening within the recommended screening 
interval increased with the number of screens a woman had previously attended. As can be 
seen in the table below, the rescreen rate is greater for women who have attended for two 
previous screens than for women who have been screened only once before, and greater still 
for women who have previously attended three or more screening episodes.  
One of the objectives of the BreastScreen Australia Program is ‘To rescreen all women in the 
Program at two-yearly intervals’ (BSANAC & DHAC 2000).  
Age-standardised rescreen rates for women aged 40 years and over, screened during 2000, Australia 
 First screening round Second screening round
Subsequent screening 
rounds
Rate (%) 61.8 72.0 80.6
95% CI 61.3–62.3 71.6–72.4 80.3–81.0
Source: AIHW analysis of BreastScreen Australia data. 
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Rescreen rate for women aged 50–67 years, screened during 2000, 
first screening round 
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Note: Bars on columns represent 95% confidence intervals. 
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 66.3 62.7* 67.7 71.1* 60.3* 66.5 68.5 56.1* 49.6*
95% CI 65.5–67.1 61.4–64.0 65.8–69.7 69.6–72.6 57.0–63.8 62.7–70.4 63.1–74.1 48.9–63.7 39.2–60.8
* Significantly different from the all-Australia rate. 
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
• The age-standardised national rescreen rate for women aged 50–67 years returning for 
screening within 27 months of attending a BreastScreen Australia service in 2000 for the 
first time was 66.3%. Of all women aged 40 and over, 61.8% returned for screening. 
• Across the states and territories, the age-standardised rescreen rates for women in the 
target age group ranged from 49.6% in the Northern Territory to 71.1% in Queensland. 
The rate for Queensland was significantly higher than the national rate. 
 
 
 
 
 
For more information, see: 
Tables 37 and 38 
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Rescreen rate for women aged 50–67 years, screened during 2000, 
second screening round 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 75.7 72.2* 75.4 80.3* 69.6* 78.0 76.8 62.4* 64.3*
95% CI 75.1–76.3 71.1–73.3 73.5–77.3 79.2–81.3 67.4–71.9 75.4–80.7 72.7–81.0 56.1–69.1 57.6–71.3
* Significantly different from the all-Australia rate. 
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
• The age-standardised national rescreen rate for women aged 50–67 years returning for 
screening within 27 months of attending a BreastScreen Australia service in 2000 for the 
second time was 75.7%. This is significantly higher than the rate for women attending for 
their first visit. 
• Across the states and territories, the age-standardised rescreen rates for the target age 
group ranged from 62.4% in the Australian Capital Territory to 80.3% in Queensland. 
The rate for Queensland was significantly higher than the national rate. 
 
 
 
 
 
For more information, see: 
Tables 39 and 40 
  34 
 
 
 
Rescreen rate for women aged 50–67 years, screened during 2000, 
third and subsequent screening rounds 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW analysis of BreastScreen Australia data. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate (%) 84.2 81.8* 85.3* 87.0* 81.9* 88.4* 85.2 75.7* 80.3
95% CI 83.9–84.4 81.3–82.3 84.8–85.7 86.2–87.8 81.1–82.7 87.6–89.3 83.6–86.8 73.5–78.0 74.1–86.8
* Significantly different from the all-Australia rate. 
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
• The age-standardised national rescreen rate for women aged 50–67 years returning for 
screening within 27 months of attending a BreastScreen Australia service in 2000 for their 
third or subsequent visit was 84.2%. This is significantly higher than the rate for women 
attending for their second visit. 
• Across the states and territories, the age-standardised rescreen rates for the target age 
group ranged from 75.7% in the Australian Capital Territory to 88.4% in South Australia. 
Rescreen rates in Victoria, Queensland and South Australia were significantly higher 
than the national rate. 
 
 
 
For more information, see: 
Tables 41 and 42 
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Indicator 7: Incidence 
7a. Incidence of breast cancer 
The incidence of breast cancer is calculated per 100,000 estimated resident female population 
in a 12-month period by five-year age groups (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34,  
35–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, 80–84, 85+ years) and for the 
target age group (50–69 years).  
7b. Incidence of ductal carcinoma in situ 
The incidence of DCIS is calculated per 100,000 estimated resident female population in a 
six-year period by ten-year age groups (0–19, 20–29, 30–39, 40–49, 50–59, 60–69, 70+ years) 
and for the target age group (50–69 years). 
The incidence indicator 
Registration of cancer cases is required by law in each of the states and territories. The data 
are collected by state and territory cancer registries and compiled in a national database, the 
National Cancer Statistics Clearing House, which is held by the Australian Institute of 
Health and Welfare (AIHW). The data include clinical and demographic information about 
people with newly diagnosed cancer. The incidence indicator measures the number of new 
cases of breast cancer in the community each year. It does not distinguish between screen-
detected cancers and other detection methods.  
Incidence data provide information about the underlying level of breast cancer in the 
Australian community. This knowledge can be used to assist in developing policies on breast 
cancer screening. For example, examining the trends in breast cancer incidence in different 
age groups helps to identify the ages at which women are most at risk of developing breast 
cancer. Incidence data can also be used to set performance standards for breast cancer 
detection. 
This chapter reports the rates of breast cancer from 1987 to 2001, the latest national data 
available. This chapter also reports on breast cancer incidence by state and territory, and by 
geographical region. 
Similarly, data on the incidence of DCIS provide information about the underlying level of 
the condition among Australian women. Data are required to build more knowledge about 
DCIS, which was rarely detected before screening was introduced. Since the introduction of 
screening mammography, the detection of DCIS has increased (NBCC et al. 2000). More 
information is given on DCIS in the chapter headed ‘Indicator 4’. 
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Incidence of breast cancer in women, Australia, 1987–2001 
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Source: AIHW National Cancer Statistics Clearing House. 
 
 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
All 
ages 91.2 89.6 93.4 94.8 100.4 98.2 105.4 114.0 115.7 109.2 111.3 114.6 111.3 115.6 117.2
<50  38.2 36.7 37.2 38.1 38.8 39.8 40.5 41.3 41.6 39.9 39.4 40.2 39.1 40.7 40.4
50–69  196.9 194.5 208.1 209.7 230.3 222.0 250.8 282.0 285.3 269.6 276.7 289.2 287.7 296.2 305.4
70+  279.4 279.6 287.6 292.4 304.5 290.5 301.7 323.1 331.4 307.6 319.7 322.1 298.1 314.7 314.7
 Note: Rates are the number of breast cancers detected per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
• With some fluctuations, a notable increase over the period 1987 to 2001 can be seen in the 
age-standardised breast cancer incidence rates for women in the target age group. 
Incidence has increased in this group from 196.9 new cancers per 100,000 women in 1987 
to 305.4 per 100,000 women in 2001. A similar pattern of increase in incidence rates is 
apparent in the 70 and over age group. Incidence rates have remained more consistent 
over time in the ‘all ages’ category and in women under 50 years of age. 
• The increase in the rate of new cancers, especially in the target age group, corresponds 
with the introduction in 1991 of BreastScreen Australia (then known as the National 
Program for the Early Detection of Breast Cancer). Although the underlying rate for 
breast cancer is increasing, the sharp increase between 1992 and 1994 is likely to be, at 
least partly, the result of the early detection of cancers in women who may otherwise 
have gone undiagnosed for some years. 
For more information, see:  
Tables 43 and 44 
  37 
 
 
 
Incidence of breast cancer in women aged 50–69 years, 1998–2001 
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW National Cancer Statistics Clearing House. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 294.9 286.3 290.9 305.0 299.3 316.2* 278.9 341.3* 242.9
95% CI 290.9–298.9 279.7–293.0 283.1–298.8 295.6–314.6 286.4–312.7 302.3–330.7 255.6–303.7 307.2–378.1 197.4–295.5
* Significantly different from the all-Australia rate. 
 Note: Rates are the number of breast cancers detected per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
 
• The national age-standardised incidence rate for 1998 to 2001 was 294.9 new cancers per 
100,000 women. Across the states and territories, incidence rates ranged from 242.9 new 
cancers per 100,000 women in the Northern Territory to 341.3 new cases per 100,000 
women in the Australian Capital Territory. The rates for the Australian Capital Territory 
and South Australian (316.2 per 100,000 women) were significantly above the national 
rate. 
 
 
 
For more information, see: 
Tables 45 and 46 
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Age-specific incidence rates for breast cancer in women,  
Australia, 2001 
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Source: AIHW National Cancer Statistics Clearing House. 
 
Age 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+ 
Rate 123.1 178.9 254.4 310.3 352.7 338.7 332.1 305.8 302.8 304.9 
 Note: Rates are the number of breast cancers detected per 100,000 women. 
 
• All women aged 40 and over are able to attend for screening with BreastScreen Australia, 
although the Program is specifically aimed at women aged 50–69 years of age who are 
without symptoms. Of the 11,791 new cases of breast cancer in 2001, 5,802 (49%) occurred 
in women in the target age group. Only 6% of cases were women aged under 40 years. 
• Age-specific incidence rates in 2001 ranged from 123.1 new cancers per 100,000 women in 
the 40–44 age group to 352.7 new cases per 100,000 women in the 60–64 age group.  
• The mean age at diagnosis for women diagnosed with breast cancer in 2001 was  
60 years. The median age at diagnosis was 59 years. 
 
 
 
 
 
 
For more information, see: 
Table 44 
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Incidence of breast cancer in women by region, 1997–2001 
 
Australia Major cities Inner regional Outer regional Remote Very remote
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Note: Bars on columns represent 95% confidence intervals.  
Source: AIHW National Cancer Statistics Clearing House. 
 
 Australia Major cities Inner regional Outer regional Remote Very remote
All ages 114.1 117.2* 111.3 102.3* 101.9* 91.2*
95% CI 113.1–115.0 116.0–118.4 109.3–113.4 99.5–105.2 94.1–110.2 79.2–104.3
Ages 50–69 291.4 299.4 286.7 260.9* 249.9* 209.8*
95% CI 287.9–295.0 295.0–303.9 279.3–294.3 250.7–271.4 222.8–279.4 171.0–253.0
* Significantly different from the all-Australian rate. 
 Note: Rates are the number of breast cancers detected per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
 
• For the period 1997 to 2001, the age-standardised incidence rate was 291.4 cases of breast 
cancer per 100,000 women for women in the target age group, and 114.1 cases per 100,000 
women for all women aged 40 and over. Breast cancer incidence rates for women in the 
target age group ranged from 209.8 cases per 100,000 women in very remote areas to 
299.4 cases per 100,000 women in major cities. 
 
For more information, see: 
Tables 47 and 48 
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Incidence of ductal carcinoma in situ in women aged 50–69 years, 
1996–2001 
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Note: Bars on columns represent 95% confidence intervals.  
Source: National Cancer Statistics Clearing House. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 37.5 35.3 38.2 34.5 50.0* 38.6 37.3 41.9 17.4
95% CI 35.6–39.5 32.0–38.6 34.3–42.1 30.2–39.1 43.0–57.6 32.3–45.4 26.5–49.7 25.6–61.5 2.1–41.6
* Significantly different from the all-Australia rate. 
Notes: Rates are the number of DCIS detected per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
• For the period 1996 to 2001, the national age-standardised incidence rate of DCIS for 
women aged 50–69 years was 37.5 per 100,000 women. Western Australia was the only 
state or territory to have a DCIS incidence rate significantly different from the national 
rate, with 50 cases per 100,000, well above the national rate. 
• For the period 1996 to 2001, the age-standardised incidence of DCIS ranged from  
17.4 cases per 100,000 women in the Northern Territory to 50.0 cases per 100,000 women 
in Western Australia. 
 
 
 
 
 
For more information, see: 
Tables 49 and 50 
  41 
 
 
 
Indicator 8: Mortality 
Mortality rate 
The mortality rate from breast cancer is calculated per 100,000 estimated resident female 
population in a 12-month period by 5-year age groups (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 
30–34, 35–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, 80–84, 85+ years) and for 
the target age group (50–69 years).  
The mortality indicator 
Mortality statistics are one of the most comprehensively collected national data sets. 
Registration of death is a legal requirement in Australia and, as a result, compliance is 
virtually complete. Registration of deaths is the responsibility of the Registrar of Births, 
Deaths and Marriages in each state and territory. The Registrars provide the mortality data 
to the Australian Bureau of Statistics (ABS) for coding the cause of death and compilation 
into national statistics. The AIHW also holds these data in a national mortality database. The 
data presented here are from the AIHW National Mortality Database and are based on the 
year of registration of the death. Note that about 5% of deaths are not registered until the 
year following the death (ABS 2002). 
Breast cancer is the most common cause of cancer death in Australian women. The number 
of deaths from breast cancer in recent years has remained fairly stable, with 2,609 women 
dying from the disease in 1997 and 2,698 women in 2002. However, over this period the rates 
of deaths caused by breast cancer have steadily fallen. 
In the longer term, mortality rates from breast cancer are an important indicator of the 
effectiveness of the screening program. A particularly important indication of the 
effectiveness of a screening program is the change in mortality rates over time in the target 
age group for screening. There are, however, two difficulties with using these mortality rates 
as an indicator of screening effectiveness. The first is that changes in mortality over time may 
reflect factors additional to screening, such as new and more effective treatments. The 
second is that changes in the mortality rates may not be apparent for a number of years 
following the commencement of a screening program. Accordingly, this is a measure that 
needs to be viewed over the long term and interpreted with caution.  
The mortality rates presented in this chapter are for the total female population of Australia, 
not only for those women who participated in the BreastScreen Australia Program. 
This chapter shows the trend in breast cancer mortality from 1988 to 2002, the latest national 
data available. It also reports on breast cancer mortality by state and territory, by age, by 
region and by Indigenous status. 
Some changes have been made to the coding and processing of mortality data. These are 
described in Appendix A. 
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Mortality from breast cancer, females, Australia, 1988–2002 
 
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
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All  ages
70+ years
<50 years
 
 
Source: AIHW National Mortality Database. 
 
 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
All ages 30.5 30.8 30.4 30.5 28.9 30.5 30.0 28.9 28.1 27.8 26.5 25.4 24.7 24.7 25.1
<50 7.3 7.9 7.5 7.8 7.6 7.1 7.4 6.5 6.9 7.2 6.6 6.4 5.9 5.7 5.4
50–69 68.3 66.7 68.5 66.5 60.6 67.9 65.5 64.6 61.5 60.6 57.3 55.0 52.5 51.8 56.7
70+ 131.2 134.1 127.9 130.9 127.4 133.9 131.3 128.0 122.9 119.7 117.3 111.4 112.7 115.9 112.0
Note: Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 
2001. 
• Since 1993 the age-standardised mortality rates for women in the target age group have 
declined steadily. The mortality rate for these women was 68.3 deaths per 100,000 
women in 1988; in 2001 the corresponding figure was 51.8 deaths per 100,000 women. 
There was a small increase in the mortality rate in 2002, rising to 56.7 deaths per 100,000 
women. However, this increase was not statistically significant. A similar pattern of 
decline in mortality rates can be observed in women aged 70 and over. Mortality rates for 
women aged under 50 years remained the lowest and most consistent, staying below 8 
deaths per 100,000 women for the period 1988 to 2002. 
 
 
 
 
For more information, see: 
Tables 51 and 52 
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Mortality from breast cancer in women aged 50–69, 1999–2002 
 
Australia NSW Vic Qld WA SA Tas ACT NT
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Note: Bars on columns represent 95% confidence intervals. 
Source: AIHW National Mortality Database. 
 
 Australia NSW Vic Qld WA SA Tas ACT NT
Rate 54.0 53.6 54.9 50.3 51.1 59.2 62.1 61.2 64.2
95% CI 52.3–55.7 50.8–56.5 51.6–58.4 46.6–54.2 46.0–56.7 53.3–65.5 51.6–74.2 47.3–77.9 42.1–93.3
Notes  
1. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
2. None of the rates was significantly different from the all-Australia rate. 
• The national age-standardised mortality rate was 54.0 deaths per 100,000 women for the 
period 1999 to 2002. Across the states and territories, the mortality rate ranged from  
50.3 deaths per 100,000 women in Queensland to 64.2 deaths per 100,000 women in the 
Northern Territory, despite the incidence rate in the Northern Territory being the lowest 
of any state or territory (Tables 45 and 46). 
 
 
 
 
 
 
For more information, see: 
Tables 53 and 54 
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Age-specific mortality rates for breast cancer, females, Australia, 
2002 
 
 
 
Source: AIHW National Mortality Database. 
 
Age 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+
Rate 14.7 25.0 45.4 54.0 65.0 72.0 73.6 105.9 131.0 192.6
Note: Rates are the number of deaths from breast cancer per 100,000 women. 
• In 2002, age-specific mortality rates increased consistently with age. For women aged  
40–44 years, the rate was 14.7 deaths per 100,000 women. The rate increased to  
192.6 deaths per 100,000 women for women aged 85 and over.  
• The pattern of breast cancer mortality by age group has remained the same over the 
period 1988 to 2002 (Table 51). 
• The mean age at death for women dying from breast cancer in 2002 was 67 years. The 
median age at death was also 67 years. 
 
 
 
 
 
 
 
For more information, see: 
Tables 51 and 52 
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Mortality from breast cancer by region, females, 1998–2002 
 
Australia Major cities Inner regional Outer regional Remote Very remote
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Source: AIHW National Mortality Database. 
 
 Australia Major cities Inner regional Outer regional Remote Very remote
All ages 25.3 25.3 25.3 25.4 22.6 22.6
95% CI 24.8–25.7 24.8–25.9 24.4–26.3 24.0–26.8 18.9–26.7 16.8–29.5
Ages 50–69 54.6 55.6 52.8 54.1 45.9 51.8
95% CI 53.1–56.1 53.8–57.5 49.6–56.0 49.6–59.0 34.9–59.3 33.8–75.9
Notes  
1. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
2. The Australian Standard Geographical Classification (ASGC) was used to create the above categories (ABS 2001). 
3. None of the rates was significantly different from the all-Australia rate. 
• Across all regions, mortality rates were significantly higher for women in the target age 
group than the ‘all ages’ group.  
• For women in the target age group, mortality rates were highest in major cities with  
55.6 deaths per 100,000 women, and lowest in remote areas, with 45.9 deaths per 100,000 
women. These differences were not statistically significant because the relatively small 
number of deaths in remote areas have wide confidence intervals. The actual number of 
deaths by region can be seen in Table 55. 
 
 
For more information, see: 
Tables 55 and 56 
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Mortality from breast cancer by Indigenous status, females,  
1998–2002 
 
Australia Indigenous Non-Indigenous
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Source: AIHW National Mortality Database. 
 
 Australia Indigenous Non-Indigenous
All ages 25.4 30.9 24.8
95% CI 25.0–25.9 23.1–40.4 24.1–25.6
Ages 50–69 54.6 46.4 53.0
95% CI 53.1–56.1 28.9–70.5 50.5–55.5
Notes  
1. Only Queensland, Western Australia, South Australia and the Northern Territory had Indigenous death registration data considered to be of 
a publishable standard at the time this report was prepared. Therefore data from these jurisdictions only are included in the analysis by 
Indigenous status.  
2. ‘Australia’ includes all states and territories. 
3. Women whose Indigenous status was recorded as ‘not stated’ are included in the analysis for all women but excluded from the analysis by 
Indigenous status. 
4. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
5. None of the rates was significantly different from the all-Australia rate. 
• In the target age group, the age-standardised mortality rate for Indigenous women  
(46.4 deaths per 100,000 women) was lower than that for non-Indigenous women  
(53.0 deaths per 100,000 women). However, this difference was not significant.  
• Nationally and among non-Indigenous women, the mortality rate was significantly 
higher for women in the target age group than for all women. There was no significant 
difference between age groups for Indigenous women. 
For more information, see: 
Tables 57 and 58 
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Indicator 1: Participation 
Table 1: Number of women participating in BreastScreen Australia by age, states and territories, 
2001–2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
40–44 43,630 11,142 33,786 7,118 6,319 2,716 1,125 735 106,571
45–49 73,009 20,464 49,513 15,581 12,819 5,571 3,053 1,364 181,374
50–54 105,512 90,654 68,239 33,319 33,533 8,881 6,441 2,374 348,953
55–59 96,035 78,822 59,039 27,343 28,384 8,417 5,166 1,749 304,955
60–64 79,426 63,975 46,513 22,305 23,000 6,795 3,576 1,010 246,600
65–69 66,111 52,843 36,907 18,032 19,120 5,575 2,593 538 201,719
70–74 53,087 42,364 28,590 5,096 6,949 2,615 588 312 139,601
75–79 32,771 11,343 10,136 2,049 3,158 682 268 126 60,533
80–84 11,057 1,707 2,886 522 735 158 77 66 17,208
85+ 2,445 364 675 115 106 25 11 7 3,748
Ages 40+ 563,083 373,678 336,284 131,480 134,123 41,435 22,898 8,281 1,611,262
Ages 50–69 347,084 286,294 210,698 100,999 104,037 29,668 17,776 5,671 1,102,227
Note: Period covers 1 January 2001 to 31 December 2002. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 2: Percentage of women participating in BreastScreen Australia, states and territories,  
2001–2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–44 17.3 6.0 23.9 9.5 10.8 14.7 8.7 9.8 14.2
45–49 31.9 12.1 38.5 22.2 23.5 32.5 24.9 20.9 26.4
50–54 49.0 56.4 55.7 51.9 63.3 54.5 54.7 42.5 53.7
55–59 55.1 61.9 60.3 56.8 66.4 63.1 62.1 49.6 59.1
60–64 56.0 61.6 61.2 57.7 66.8 61.2 62.5 45.5 59.6
65–69 53.9 58.6 60.0 56.7 63.7 59.6 59.5 40.5 57.4
70–74 44.9 49.1 49.9 17.8 23.1 29.8 15.8 32.9 41.8
75–79 31.5 14.8 20.6 8.5 11.4 8.8 8.0 20.7 20.6
80–84 15.0 3.2 8.2 3.1 3.7 2.8 3.5 15.8 8.3
85+ 3.7 0.7 2.2 0.7 0.6 0.5 0.6 2.2 2.0
Ages 40+              
Crude rate 37.6 33.9 42.0 31.8 36.4 36.7 34.5 28.6 36.7
ASR(A) 38.3 34.8 42.6 32.4 37.8 37.6 34.3 29.8 37.5
95% CI 38.2–38.4 34.6–34.9 42.5–42.7 32.2–32.6 37.6–38.0 37.2–38.0 33.8–34.7 29.1–30.6 37.4–37.6
Ages 50–69              
Crude rate 53.1 59.4 58.9 55.3 64.9 59.2 58.9 44.8 57.1
ASR(A) 53.0 59.4 58.9 55.3 64.9 59.1 59.2 44.7 57.1
95% CI 52.8–53.2 59.2–59.6 58.6–59.1 55.0–55.7 64.5–65.3 58.5–59.8 58.3–60.1 43.5–45.9 57.0–57.2
Notes 
1. Period covers 1 January 2001 to 31 December 2002. 
2. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
3. BreastScreen Australia services are not provided in some remote areas of the Northern Territory. This may affect the Northern Territory’s 
participation rate. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 3: Participation in BreastScreen Australia by age and region, 2001–2002 
Age group 
Number/ 
rate Major cities Inner regional Outer regional Remote Very remote Australia
40–44 Number 65,739 22,939 14,351 2,422 1,120 106,571
 Rate 13.2 14.4 18.5 19.9 19.2 14.2
45–49 Number 112,870 40,380 22,886 3,738 1,500 181,374
 Rate 24.6 27.8 32.9 35.8 30.4 26.4
50–54 Number 228,708 75,496 37,450 5,362 1,938 348,953
 Rate 52.7 55.5 57.1 56.6 44.7 53.7
55–59 Number 193,629 70,867 34,177 4,706 1,576 304,955
 Rate 57.6 62.1 62.4 63.6 50.7 59.1
60–64 Number 152,732 60,332 28,846 3,526 1,163 246,600
 Rate 57.8 62.8 63.1 63.0 50.9 59.6
65–69 Number 124,953 50,202 23,135 2,680 749 201,719
 Rate 55.5 60.7 61.9 62.3 46.3 57.4
70–74 Number 87,232 35,341 15,015 1,576 437 139,601
 Rate 40.0 45.6 44.5 45.0 35.2 41.8
75–79 Number 38,866 14,621 6,197 647 202 60,533
 Rate 19.8 22.2 22.3 24.2 22.9 20.6
80–84 Number 11,035 4,150 1,754 213 56 17,208
 Rate 7.9 9.0 9.1 11.5 9.3 8.3
85+ Number 2,360 913 405 51 19 3,748
 Rate 1.9 2.2 2.3 3.2 3.8 2.0
Ages 40+ Number 1,018,122 375,242 184,217 24,922 8,759 1,611,262
 Crude rate 35.2 38.9 41.0 42.2 34.6 36.7
 ASR(A) 36.2 39.4 41.3 42.4 34.6 37.5
 95% CI 36.1–36.2 39.3–39.5 41.1–41.5 41.8–42.9 33.9–35.4 37.4–37.6
Ages 50–69 Number 700,022 256,897 123,608 16,275 5,425 1,102,227
 Crude rate 55.6 59.9 60.8 60.8 47.8 57.1
 ASR(A) 55.6 59.7 60.7 60.9 47.9 57.1
 95% CI 55.5–55.7 59.5–60.0 60.3–61.0 59.9–61.8 46.6–49.2 57.0–57.2
Notes 
1. Period covers 1 January 2001 to 31 December 2002.  
2. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
3. The Australian Standard Geographical Classification (ASGC) was used to create the above categories (ABS 2001). 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 4: Participation in BreastScreen Australia by age and socioeconomic status, 2001–2002 
Age group Number/ rate  1st quintile 2nd quintile 3rd quintile 4th quintile 5th quintile Australia
40–44 Number 21,020 19,955 23,154 22,397 20,045 106,571
 Rate 13.4 13.0 15.4 15.4 13.7 14.2
45–49 Number 37,540 32,860 38,709 38,019 34,246 181,374
 Rate 25.2 23.3 28.6 28.8 26.1 26.4
50–54 Number 77,887 69,952 70,317 68,132 62,667 348,953
 Rate 54.0 53.0 56.1 54.9 50.7 53.7
55–59 Number 65,631 58,345 61,598 61,941 57,439 304,955
 Rate 59.2 57.3 60.8 60.3 58.1 59.1
60–64 Number 47,840 45,582 50,433 53,025 49,721 246,600
 Rate 58.9 58.2 60.1 60.8 59.7 59.6
65–69 Number 37,420 36,724 41,156 45,249 41,169 201,719
 Rate 56.9 56.6 57.1 59.3 57.1 57.4
70–74 Number 27,102 25,952 29,300 30,109 27,138 139,601
 Rate 42.1 42.2 42.5 42.0 40.4 41.8
75–79 Number 12,967 9,993 12,872 13,341 11,360 60,533
 Rate 21.4 18.1 21.2 22.2 20.1 20.6
80–84 Number 3,818 2,724 3,711 3,828 3,128 17,208
 Rate 8.4 6.9 8.6 9.4 8.3 8.3
85+ Number 819 537 833 853 707 3,748
 Rate 1.8 1.5 2.2 2.5 2.2 2.0
Ages 40+ Number 332,044 302,624 332,082 336,893 307,619 1,611,262
 Crude rate 35.9 35.0 37.8 38.5 36.3 36.7
 ASR(A) 37.2 36.1 38.8 38.9 36.6 37.5
 95% CI 37.1–37.3 35.9–36.2 38.6–38.9 38.7–39.0 36.5–36.8 37.4–37.6
Ages 50–69 Number 228,778 210,603 223,504 228,347 210,996 1,102,227
 Crude rate 56.9 55.8 58.4 58.5 55.8 57.1
 ASR(A) 57.0 55.9 58.4 58.4 55.7 57.1
 95% CI 56.7–57.2 55.6–56.1 58.2–58.6 58.1–58.6 55.5–56.0 57.0–57.2
Notes  
1. Period covers 1 January 2001 to 31 December 2002. 
2. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
3. The first quintile corresponds to the highest level of socioeconomic status and the fifth to the lowest. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 5: Participation in BreastScreen Australia by age and Indigenous status, 2001–2002 
Age group Number/rate Indigenous Non-Indigenous Australia
40–44 Number 1,473 102,227 106,571
 Rate 10.9 13.8 14.2
45–49 Number 2,097 174,009 181,374
 Rate 20.0 25.7 26.4
50–54 Number 2,609 324,085 348,953
 Rate 31.7 50.6 53.7
55–59 Number 2,005 285,183 304,955
 Rate 36.4 55.9 59.1
60–64 Number 1,542 230,901 246,600
 Rate 36.4 56.4 59.6
65–69 Number 1,046 189,080 201,719
 Rate 36.3 54.3 57.4
70–74 Number 551 130,844 139,601
 Rate 27.4 39.4 41.8
75+ Number 219 78,354 81,489
 Rate 8.7 11.4 11.9
Ages 40+ Number 11,542 1,514,683 1,611,262
 Crude rate 23.4 34.9 36.7
 ASR(A) 24.2 35.6 37.4
 95% CI 23.7–24.6 35.5–35.6 37.3–37.5
Ages 50–69 Number 7,202 1,029,249 1,102,227
 Crude rate 34.6 53.9 57.1
 ASR(A) 34.8 53.9 57.1
 95% CI 34.0–35.6 53.8–54.0 57.0–57.2
Notes  
1. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
2. Period covers 1 January 2001 to 31 December 2002. 
3. Women in the ‘unknown’ category are included in the column for all women, but are not included in the other columns. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 6: Participation in BreastScreen Australia by age and main language spoken at home,  
2001–2002 
Age group Number/rate  English-speaking Non-English-speaking Australia
40–44 Number 92,787 13,451 106,571
 Rate 14.9 10.4 14.2
45–49 Number 157,380 23,438 181,374
 Rate 27.5 20.4 26.4
50–54 Number 302,313 45,641 348,953
 Rate 55.4 44.1 53.7
55–59 Number 264,460 39,711 304,955
 Rate 60.6 50.0 59.1
60–64 Number 208,276 37,758 246,600
 Rate 61.5 50.1 59.6
65–69 Number 170,383 30,976 201,719
 Rate 59.8 46.9 57.4
70–74 Number 122,684 16,683 139,601
 Rate 43.8 31.1 41.8
75–79 Number 54,480 5,974 60,533
 Rate 21.9 13.4 20.6
80–84 Number 16,032 1,146 17,208
 Rate 8.7 4.9 8.3
85+ Number 3,537 208 3,748
 Rate 2.1 1.1 2.0
Ages 40+ Number 1,392,332 214,986 1,611,262
 Crude rate 37.8 30.3 36.7
 ASR(A) 38.9 30.1 37.5
 95% CI 38.8–38.9 29.9–30.2 37.4–37.6
Ages 50–69 Number 945,432 154,086 1,102,227
 Crude rate 58.9 47.5 57.1
 ASR(A) 58.9 47.4 57.1
 95% CI 58.8–59.0 47.2–47.7 57.0–57.2
Notes  
1. Period covers 1 January 2001 to 31 December 2002. 
2. Rates are the number of women screened as a percentage of the eligible female population and age-standardised to the Australian 
population at 30 June 2001. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 2: Detection rate for small invasive cancers 
Table 7: Numbers of women screened and cases of small-diameter (≤ 15 mm) invasive cancers 
detected in these women, first screening round, by age, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 13,402 4,758 10,296 2,209 1,904 821 53 191 33,634
 Cases 16 4 15 1 2 2 0 0 40
45–49 Screened 10,513 5,672 6,227 2,763 2,077 605 71 218 28,146
 Cases 14 7 20 3 2 1 0 0 47
50–54 Screened 13,400 12,430 6,945 5,564 4,027 638 652 319 43,975
 Cases 31 24 19 21 12 0 3 0 110
55–59 Screened 6,378 2,853 3,231 1,313 785 299 225 86 15,170
 Cases 20 10 12 2 3 0 2 0 49
60–64 Screened 4,190 1,949 2,261 851 380 184 118 44 9,977
 Cases 17 8 13 7 5 2 0 1 53
65–69 Screened 3,027 1,459 1,552 541 229 108 61 26 7,003
 Cases 17 9 9 3 6 0 0 0 44
70–74 Screened 1,708 843 801 168 113 38 18 16 3,705
 Cases 12 6 9 1 1 0 0 0 29
75–79 Screened 1,088 494 490 113 114 37 25 8 2,369
 Cases 6 2 1 1 2 0 0 0 12
80–84 Screened 436 191 156 49 64 11 6 3 916
 Cases 2 2 1 0 2 0 0 0 7
85+ Screened 118 49 53 17 8 4 0 0 249
 Cases 2 0 1 0 0 0 0 0 3
Ages 40+ Screened 54,260 30,698 32,012 13,588 9,701 2,745 1,229 911 145,144
 Cases 137 72 100 39 35 5 5 1 394
Ages 50–69 Screened 26,995 18,691 13,989 8,269 5,421 1,229 1,056 475 76,125
 Cases 85 51 53 33 26 2 5 1 256
Source: AIHW analysis of BreastScreen Australia data. 
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Table 8: Age-specific rates of small-diameter (≤ 15 mm) invasive cancers detected in women 
screened, first screening round, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
40–44  11.9  8.4  14.6  4.5  10.5  24.4  0.0  0.0  11.9
45–49  13.3  12.3  32.1  10.9  9.6  16.5  0.0  0.0  16.7
50–54  23.1  19.3  27.4  37.7  29.8  0.0  46.0  0.0  25.0
55–59  31.4  35.1  37.1  15.2  38.2  0.0  88.9  0.0  32.3
60–64  40.6  41.0  57.5  82.3  131.6  108.7  0.0  227.3  53.1
65–69  56.2  61.7  58.0  55.5  262.0  0.0  0.0  0.0  62.8
70–74  70.3  71.2  112.4  59.5  88.5  0.0  0.0  0.0  78.3
75–79  55.1  40.5  20.4  88.5  175.4  0.0  0.0  0.0  50.7
80–84  45.9  104.7  64.1  0.0  312.5  0.0  0.0  0.0  76.4
85+  169.5  0.0  188.7  0.0  0.0  0.0 . . . .  120.5
Ages 40+              
Crude rate 25.2 23.5 31.2 28.7 36.1 18.2 40.7 11.0 27.1
ASR(A) 34.7 34.7 44.6 39.6 84.1 20.1 25.4 33.6 39.1
95% CI 28.4–41.8 25.7–45.4 34.6–56.2 23.7–59.8 50.0–128.0 2.5–54.8 6.8–62.1 0.8–187.1 34.6–43.9
Ages 50–69              
Crude rate 31.5 27.3 37.9 39.9 48.0 16.3 47.3 21.1 33.6
ASR(A) 35.5 36.4 42.5 45.2 99.7 24.0 38.0 50.3 40.5
95% CI 27.9–44.5 25.5–50.0 31.2–56.4 27.2–68.6 54.8–159.8 2.9–86.8 10.2–93.0 1.3–280.0 35.1–46.4
. .  Not applicable—no women in this age group screened in 2002. 
Note: Rates are the number of women with small invasive cancers detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 9: Numbers of women screened and cases of small-diameter (≤ 15 mm) invasive cancers 
detected in these women, subsequent screening rounds, by age, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 8,975 970 7,532 1,334 1,259 630 266 130 21,096
 Cases 7 0 6 0 1 2 0 0 16
45–49 Screened 27,505 4,793 19,961 5,172 4,504 2,325 1,268 493 66,021
 Cases 24 11 38 5 7 3 5 0 93
50–54 Screened 41,214 32,554 29,251 12,047 13,385 4,052 2,808 922 136,233
 Cases 85 46 54 22 27 7 4 2 247
55–59 Screened 44,772 36,210 29,285 13,539 13,884 4,364 2,682 804 145,540
 Cases 113 102 88 37 38 16 11 0 405
60–64 Screened 37,151 30,222 22,610 11,100 11,025 3,368 1,797 431 117,704
 Cases 126 91 67 33 40 13 3 1 374
65–69 Screened 31,253 25,425 17,812 9,130 9,495 2,807 1,313 236 97,471
 Cases 120 78 65 42 56 15 6 0 382
70–74 Screened 25,851 20,856 14,114 2,538 3,350 1,525 279 143 68,656
 Cases 90 73 69 7 13 7 1 1 261
75–79 Screened 16,370 5,234 3,607 975 1,611 295 117 56 28,265
 Cases 65 28 22 6 10 0 0 0 131
80–84 Screened 5,506 652 800 234 319 72 30 30 7,643
 Cases 28 4 8 2 2 1 0 0 45
85+ Screened 1,170 100 180 36 38 6 4 5 1,539
 Cases 5 0 0 2 1 0 1 0 9
Ages 40+ Screened 239,767 157,016 145,152 56,105 58,870 19,444 10,564 3,250 690,168
 Cases 663 433 417 156 195 64 31 4 1,963
Ages 50–69 Screened 154,390 124,411 98,958 45,816 47,789 14,591 8,600 2,393 496,948
 Cases 444 317 274 134 161 51 24 3 1,408
Source: AIHW analysis of BreastScreen Australia data. 
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Table 10: Age-specific rates of small-diameter (≤ 15 mm) invasive cancers detected in women 
screened, subsequent screening rounds, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
40–44  7.8  0.0  8.0  0.0  7.9  31.7  0.0  0.0  7.6
45–49  8.7  23.0  19.0  9.7  15.5  12.9  39.4  0.0  14.1
50–54  20.6  14.1  18.5  18.3  20.2  17.3  14.2  21.7  18.1
55–59  25.2  28.2  30.0  27.3  27.4  36.7  41.0  0.0  27.8
60–64  33.9  30.1  29.6  29.7  36.3  38.6  16.7  23.2  31.8
65–69  38.4  30.7  36.5  46.0  59.0  53.4  45.7  0.0  39.2
70–74  34.8  35.0  48.9  27.6  38.8  45.9  35.8  69.9  38.0
75–79  39.7  53.5  61.0  61.5  62.1  0.0  0.0  0.0  46.3
80–84  50.9  61.3  100.0  85.5  62.7  138.9  0.0  0.0  58.9
85+  42.7  0.0  0.0  555.6  263.2  0.0  2,500.0  0.0  58.5
Ages 40+              
Crude rate 27.7 27.6 28.7 27.8 33.1 32.9 29.3 12.3 28.4
ASR(A) 25.2 24.4 28.2 26.3 30.9 32.0 31.3 14.0 26.2
95% CI 23.3–27.3 21.7–27.2 25.5–31.1 22.0–31.1 26.5–35.9 24.2–41.3 18.6–48.0 3.0–37.5 25.0–27.4
Ages 50–69              
Crude rate 28.8 25.5 27.7 29.2 33.7 35.0 27.9 12.5 28.3
ASR(A) 28.2 24.5 27.4 28.5 33.2 34.1 27.8 12.2 27.8
95% CI 25.6–31.0 21.9–27.4 24.3–30.9 23.9–33.8 28.2–38.7 25.3–44.8 17.7–41.6 2.3–36.0 26.3–29.3
Note: Rates are the number of women with small invasive cancers detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 11: Numbers of women screened and cases of small-diameter (≤ 15 mm) invasive cancers 
detected in these women, all screening rounds, by age, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 22,377 5,728 17,828 3,543 3,163 1,451 319 321 54,730
 Cases 23 4 21 1 3 4 0 0 56
45–49 Screened 38,018 10,465 26,188 7,935 6,581 2,930 1,339 711 94,167
 Cases 38 18 58 8 9 4 5 0 140
50–54 Screened 54,614 44,984 36,196 17,611 17,412 4,690 3,460 1,241 180,208
 Cases 116 70 73 43 39 7 7 2 357
55–59 Screened 51,150 39,063 32,516 14,852 14,669 4,663 2,907 890 160,710
 Cases 133 112 100 39 41 16 13 0 454
60–64 Screened 41,341 32,171 24,871 11,951 11,405 3,552 1,915 475 127,681
 Cases 143 99 80 40 45 15 3 2 427
65–69 Screened 34,280 26,884 19,364 9,671 9,724 2,915 1,374 262 104,474
 Cases 137 87 74 45 62 15 6 0 426
70–74 Screened 27,559 21,699 14,915 2,706 3,463 1,563 297 159 72,361
 Cases 102 79 78 8 14 7 1 1 290
75–79 Screened 17,458 5,728 4,097 1,088 1,725 332 142 64 30,634
 Cases 71 30 23 7 12 0 0 0 143
80–84 Screened 5,942 843 956 283 383 83 36 33 8,559
 Cases 30 6 9 2 4 1 0 0 52
85+ Screened 1,288 149 233 53 46 10 4 5 1,788
 Cases 7 0 1 2 1 0 1 0 12
Ages 40+ Screened 294,027 187,714 177,164 69,693 68,571 22,189 11,793 4,161 835,312
 Cases 800 505 517 195 230 69 36 5 2,357
Ages 50–69 Screened 181,385 143,102 112,947 54,085 53,210 15,820 9,656 2,868 573,073
 Cases 529 368 327 167 187 53 29 4 1,664
Source: AIHW analysis of BreastScreen Australia data. 
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Table 12: Age-specific rates of small-diameter (≤ 15 mm) invasive cancers detected in women 
screened, all screening rounds, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
40–44 10.3 7.0 11.8 2.8 9.5 27.6 0.0 0.0 10.2
45–49 10.0 17.2 22.1 10.1 13.7 13.7 37.3 0.0 14.9
50–54 21.2 15.6 20.2 24.4 22.4 14.9 20.2 16.1 19.8
55–59 26.0 28.7 30.8 26.3 28.0 34.3 44.7 0.0 28.2
60–64 34.6 30.8 32.2 33.5 39.5 42.2 15.7 42.1 33.4
65–69 40.0 32.4 38.2 46.5 63.8 51.5 43.7 0.0 40.8
70–74 37.0 36.4 52.3 29.6 40.4 44.8 33.7 62.9 40.1
75–79 40.7 52.4 56.1 64.3 69.6 0.0 0.0 0.0 46.7
80–84 50.5 71.2 94.1 70.7 104.4 120.5 0.0 0.0 60.8
85+ 54.3 0.0 42.9 377.4 217.4 0.0 2,500.0 0.0 67.1
Ages 40+              
Crude rate 27.2 26.9 29.2 28.0 33.5 31.1 30.5 12.0 28.2
ASR(A) 26.4 25.1 30.2 28.1 33.1 30.8 32.4 15.0 27.6
95% CI 24.5–28.3 22.8–27.5 27.6–32.9 24.0–32.6 28.8–37.9 23.8–39.2 19.8–48.6 4.0–36.7 26.5–28.7
Ages 50–69              
Crude rate 29.2 25.7 29.0 30.9 35.1 33.5 30.0 13.9 29.0
ASR(A) 29.1 25.6 29.1 31.2 35.7 33.1 30.1 14.6 29.1
95% CI 26.6–31.7 23.0–28.3 26.0–32.4 26.6–36.3 30.7–41.2 24.8–43.3 20.0–43.5 3.6–38.1 27.7–30.5
Note: Rates are the number of women with small invasive cancers detected per 10,000 women screened and age-standardised to the population 
of women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 13: Numbers of women screened and cases of invasive cancer detected in these women, first 
screening round, by age, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 13,402 4,758 10,296 2,209 1,904 821 53 191 33,634
 Cases 27 12 24 2 5 4 0 0 74
45–49 Screened 10,513 5,672 6,227 2,763 2,077 605 71 218 28,146
 Cases 32 18 32 8 5 1 0 1 97
50–54 Screened 13,400 12,430 6,945 5,564 4,027 638 652 319 43,975
 Cases 56 53 27 28 24 1 3 1 193
55–59 Screened 6,378 2,853 3,231 1,313 785 299 225 86 15,170
 Cases 44 16 20 6 8 3 3 0 100
60–64 Screened 4,190 1,949 2,261 851 380 184 118 44 9,977
 Cases 32 17 23 15 7 3 0 1 98
65–69 Screened 3,027 1,459 1,552 541 229 108 61 26 7,003
 Cases 25 18 16 4 6 0 0 0 69
70–74 Screened 1,708 843 801 168 113 38 18 16 3,705
 Cases 14 13 13 2 2 0 0 1 45
75–79 Screened 1,088 494 490 113 114 37 25 8 2,369
 Cases 18 4 7 4 2 0 0 0 35
80–84 Screened 436 191 156 49 64 11 6 3 916
 Cases 2 4 2 0 2 0 0 0 10
85+ Screened 118 49 53 17 8 4 0 0 249
 Cases 5 1 2 0 0 0 0 0 8
Ages 40+ Screened 54,260 30,698 32,012 13,588 9,701 2,745 1,229 911 145,144
 Cases 255 156 166 69 61 12 6 4 729
Ages 50–69 Screened 26,995 18,691 13,989 8,269 5,421 1,229 1,056 475 76,125
 Cases 157 104 86 53 45 7 6 2 460
Source: AIHW analysis of BreastScreen Australia data. 
  61 
 
 
 
Table 14: Age-specific rates of invasive breast cancers per 10,000 women screened, first screening 
round, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
40–44 20.1 25.2 23.3 9.1 26.3 48.7 0.0 0.0 22.0
45–49 30.4 31.7 51.4 29.0 24.1 16.5 0.0 45.9 34.5
50–54 41.8 42.6 38.9 50.3 59.6 15.7 46.0 31.3 43.9
55–59 69.0 56.1 61.9 45.7 101.9 100.3 133.3 0.0 65.9
60–64 76.4 87.2 101.7 176.3 184.2 163.0 0.0 227.3 98.2
65–69 82.6 123.4 103.1 73.9 262.0 0.0 0.0 0.0 98.5
70–74 82.0 154.2 162.3 119.0 177.0 0.0 0.0 625.0 121.5
75–79 165.4 81.0 142.9 354.0 175.4 0.0 0.0 0.0 147.7
80–84 45.9 209.4 128.2 0.0 312.5 0.0 0.0 0.0 109.2
85+ 423.7 204.1 377.4 0.0 0.0 0.0 . . . . 321.3
Ages 40+              
Crude rate 47.0 50.8 51.9 50.8 62.9 43.7 48.8 43.9 50.2
ASR(A) 61.6 71.5 75.7 79.7 119.9 50.9 33.1 98.4 70.6
95% CI 53.4–70.7 58.4–86.2 62.6–90.5 56.1–107.9 79.8–168.3 21.2–96.7 10.6–74.9 7.2–294.2 64.7–76.9
Ages 50–69              
Crude rate 58.2 55.6 61.5 64.1 83.0 57.0 56.8 42.1 60.4
ASR(A) 64.4 71.7 71.2 81.6 137.5 67.1 49.5 60.4 72.2
95% CI 54.1–76.0 56.0–89.8 56.2–88.9 56.7–112.1 87.0–200.6 25.8–140.5 15.8–112.1 0.0–249.9 65.0–80.0
. . Not applicable—no women in this age group screened in 2002. 
Note: Rates are the number of women with invasive cancers detected per 10,000 women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 15: Numbers of women screened and cases of invasive cancer detected in these women, 
subsequent screening rounds, by age, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 8,975 970 7,532 1,334 1,259 630 266 130 21,096
 Cases 11 0 12 1 4 4 1 0 33
45–49 Screened 27,505 4,793 19,961 5,172 4,504 2,325 1,268 493 66,021
 Cases 41 20 58 9 9 4 6 1 148
50–54 Screened 41,214 32,554 29,251 12,047 13,385 4,052 2,808 922 136,233
 Cases 128 73 95 39 45 12 5 2 399
55–59 Screened 44,772 36,210 29,285 13,539 13,884 4,364 2,682 804 145,540
 Cases 181 154 146 58 58 19 15 0 631
60–64 Screened 37,151 30,222 22,610 11,100 11,025 3,368 1,797 431 117,704
 Cases 193 129 101 49 59 19 6 1 557
65–69 Screened 31,253 25,425 17,812 9,130 9,495 2,807 1,313 236 97,471
 Cases 177 120 106 60 80 21 8 1 573
70–74 Screened 25,851 20,856 14,114 2,538 3,350 1,525 279 143 68,656
 Cases 139 112 89 15 17 9 2 1 384
75–79 Screened 16,370 5,234 3,607 975 1,611 295 117 56 28,265
 Cases 96 39 28 11 13 0 1 1 189
80–84 Screened 5,506 652 800 234 319 72 30 30 7,643
 Cases 37 4 10 2 4 2 0 0 59
85+ Screened 1,170 100 180 36 38 6 4 5 1,539
 Cases 7 1 0 2 1 0 1 0 12
Ages 40+ Screened 239,767 157,016 145,152 56,105 58,870 19,444 10,564 3,250 690,168
 Cases 1,010 652 645 246 290 90 45 7 2,985
Ages 50–69 Screened 154,390 124,411 98,958 45,816 47,789 14,591 8,600 2,393 496,948
 Cases 679 476 448 206 242 71 34 4 2,160
Source: AIHW analysis of BreastScreen Australia data. 
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Table 16: Age-specific rates of invasive breast cancers per 10,000 women screened, subsequent 
screening rounds, by age, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
40–44 12.3 0.0 15.9 7.5 31.8 63.5 37.6 0.0 15.6
45–49 14.9 41.7 29.1 17.4 20.0 17.2 47.3 20.3 22.4
50–54 31.1 22.4 32.5 32.4 33.6 29.6 17.8 21.7 29.3
55–59 40.4 42.5 49.9 42.8 41.8 43.5 55.9 0.0 43.4
60–64 52.0 42.7 44.7 44.1 53.5 56.4 33.4 23.2 47.3
65–69 56.6 47.2 59.5 65.7 84.3 74.8 60.9 42.4 58.8
70–74 53.8 53.7 63.1 59.1 50.7 59.0 71.7 69.9 55.9
75–79 58.6 74.5 77.6 112.8 80.7 0.0 85.5 178.6 66.9
80–84 67.2 61.3 125.0 85.5 125.4 277.8 0.0 0.0 77.2
85+ 59.8 100.0 0.0 555.6 263.2 0.0 2,500.0 0.0 78.0
Ages 40+              
Crude rate 42.1 41.5 44.4 43.8 49.3 46.3 42.6 21.5 43.3
ASR(A) 38.6 37.5 43.7 42.5 46.8 46.6 48.7 27.5 40.1
95% CI 36.2–41.2 34.1–41.1 40.4–47.3 36.9–48.7 41.0–53.0 36.8–58.1 32.2–69.4 9.9–58.7 38.7–41.6
Ages 50–69              
Crude rate 44.0 38.3 45.3 45.0 50.6 48.7 39.5 16.7 43.5
ASR(A) 43.1 36.9 44.9 44.2 50.0 47.9 39.5 20.4 42.7
95% CI 39.9–46.5 33.7–40.4 40.9–49.3 38.3–50.7 43.9–56.7 37.4–60.5 27.2–55.5 4.5–54.5 40.9–44.5
Note: Rates are the number of women with invasive cancers detected per 10,000 women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 3a: Interval cancer rate 
Table 17: Numbers and age-specific rates of interval cancers in women screened during 1998, 1999 
and 2000, first screening round, 0–12 months, states and territories 
Age group 
Number/ 
rate NSW Vic Qld WA SA Tas ACT NT Australia
40–49 Number 49 23 25 10 14 3 3 2 129
 Rate 6.0 7.0 4.8 5.9 9.2 5.8 8.4 11.7 6.2
50–59 Number 45 42 36 6 19 3 1 2 154
 Rate 7.3 8.1 7.3 4.8 10.3 7.0 3.5 9.5 7.6
60–69 Number 16 6 16 3 3 3 1 0 48
 Rate 5.9 5.0 6.5 6.8 6.7 18.5 13.9 0.0 6.4
70+ Number 19 6 5 1 0 0 0 0 31
 Rate 13.2 9.7 5.2 5.1 0.0 0.0 0.0 0.0 8.7
Ages 40+ Number 129 77 82 20 36 9 5 4 362
 Crude rate 7.0 7.5 6.0 5.6 8.9 7.6 6.7 9.0 6.9
 ASR(A) 7.4 7.2 6.3 5.6 7.8 9.1 7.0 6.2 7.1
 95% CI 6.0–8.9 5.4–9.2 4.9–7.9 3.0–9.4 5.1–11.2 3.5–18.3 0.6–19.5 1.6–16.0 6.3–7.9
Ages 50–69 Number 61 48 52 9 22 6 2 2 202
 Crude rate 6.9 7.5 7.0 5.3 9.6 10.2 5.6 7.7 7.3
 ASR(A) 6.7 6.8 7.0 5.6 8.8 11.8 7.8 5.6 7.1
 95% CI 5.1–8.7 4.8–9.3 5.2–9.2 2.4–11.0 5.1–13.9 4.0–26.3 0.2–30.4 0.7–20.1 6.1–8.2
Note: Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 18: Numbers and age-specific rates of interval cancers in women screened during 1998, 1999 
and 2000, first screening round, 13–24 months, states and territories 
Age group 
Number/ 
rate NSW Vic Qld WA SA Tas ACT NT Australia
40–49 Number n.a. 36 62 10 21 3 2 0 n.a.
 Rate n.a. 11.0 12.4 6.0 14.6 6.2 5.6 0.0 n.a.
50–59 Number n.a. 72 71 12 27 6 6 3 n.a.
 Rate n.a. 13.8 15.0 9.8 14.9 14.8 21.2 14.6 n.a.
60–69 Number n.a. 22 41 5 4 4 1 0 n.a.
 Rate n.a. 18.3 16.8 11.6 9.2 26.5 14.1 0.0 n.a.
70+ Number n.a. 9 9 2 1 0 1 0 n.a.
 Rate n.a. 14.5 9.5 10.5 4.7 0.0 32.9 0.0 n.a.
Ages 40+ Number n.a. 139 183 29 53 13 10 3 n.a.
 Crude rate n.a. 13.5 14.0 8.2 13.6 11.6 13.6 7.2 n.a.
 ASR(A) n.a. 14.6 14.3 9.6 12.0 14.4 17.5 5.7 n.a.
 95% CI n.a. 11.8–17.6 12.2–16.7 5.9–14.5 8.5–16.3 6.9–25.8 6.5–35.1 1.2–16.6 n.a.
Ages 50–69 Number n.a. 94 112 17 31 10 7 3 n.a.
 Crude rate n.a. 14.7 15.6 10.3 13.8 18.0 19.8 11.8 n.a.
 ASR(A) n.a. 15.7 15.8 10.5 12.5 19.7 18.3 8.5 n.a.
 95% CI n.a. 12.2–19.8 12.9–19.0 5.9–17.3 8.0–18.5 8.9–37.0 6.0–40.0 1.8–24.9 n.a.
n.a.  Not available. 
Notes 
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
2. New South Wales data were unavailable at the time of publication. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 19: Numbers and age-specific rates of interval cancers in women screened during 1998, 1999 
and 2000, first screening round, 0–24 months, states and territories 
Age group 
Number/ 
rate NSW Vic Qld WA SA Tas ACT NT Australia
40–49 Number n.a. 59 87 20 35 6 5 2 n.a.
 Rate n.a. 9.0 8.5 5.9 11.8 6.0 7.0 6.3 n.a.
50–59 Number n.a. 114 107 18 46 9 7 5 n.a.
 Rate n.a. 10.9 11.1 7.3 12.6 10.8 12.3 12.0 n.a.
60–69 Number n.a. 28 57 8 7 7 2 0 n.a.
 Rate n.a. 11.6 11.6 9.2 7.9 22.3 14.0 0.0 n.a.
70+ Number n.a. 15 14 3 1 0 1 0 n.a.
 Rate n.a. 12.1 7.3 7.8 2.3 0.0 16.4 0.0 n.a.
Ages 40+ Number n.a. 216 265 49 89 22 15 7 n.a.
 Crude rate n.a. 10.5 9.9 6.9 11.2 9.6 10.1 8.1 n.a.
 ASR(A) n.a. 10.9 10.2 7.6 9.8 11.7 12.2 6.0 n.a.
 95% CI n.a. 9.2–12.7 9.0–11.6 5.3–10.5 7.6–12.5 6.8–18.4 5.5–22.1 2.4–12.4 n.a.
Ages 50–69 Number n.a. 142 164 26 53 16 9 5 n.a.
 Crude rate n.a. 11.1 11.3 7.8 11.7 14.0 12.6 9.8 n.a.
 ASR(A) n.a. 11.2 11.3 8.1 10.6 15.6 13.0 7.0 n.a.
 95% CI n.a. 9.2–13.5 9.6–13.2 5.1–12.1 7.6–14.3 8.6–25.8 5.0–26.3 2.3–16.4 n.a.
n.a.  Not available. 
Notes 
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
2. New South Wales data were unavailable at the time of publication. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 20: Numbers and age-specific rates of interval cancers in women screened during 1998, 1999 
and 2000, subsequent screening rounds, 0–12 months, states and territories 
Age group 
Number/ 
rate NSW Vic Qld WA SA Tas ACT NT Australia
40–49 Number 76 13 55 21 18 4 3 1 191
 Rate 7.6 7.0 8.3 10.5 11.3 4.1 8.3 6.3 8.1
50–59 Number 178 138 100 48 61 19 24 1 569
 Rate 7.8 7.8 8.4 6.9 9.4 8.9 18.4 2.8 8.2
60–69 Number 151 107 63 33 33 11 13 1 412
 Rate 8.0 7.3 7.5 6.3 6.0 6.7 17.8 7.2 7.4
70+ Number 68 37 43 5 6 3 2 0 164
 Rate 5.8 5.4 8.9 6.1 4.9 12.0 18.3 0.0 6.3
Ages 40+ Number 473 295 261 107 118 37 42 3 1,336
 Crude rate 7.4 7.2 8.2 7.1 8.0 7.4 16.7 4.2 7.7
 ASR(A) 7.5 7.2 8.2 7.4 8.3 7.7 16.1 4.4 7.7
 95% CI 6.9–8.3 6.2–8.3 7.2–9.3 5.9–9.0 6.7–10.0 5.2–10.8 11.1–22.4 0.8–13.1 7.3–8.2
Ages 50–69 Number 329 245 163 81 94 30 37 2 981
 Crude rate 7.9 7.6 8.0 6.6 7.8 8.0 18.2 4.0 7.8
 ASR(A) 7.8 7.6 8.0 6.6 8.0 8.0 18.1 4.6 7.9
 95% CI 7.0–8.7 6.7–8.6 6.8–9.4 5.3–8.3 6.4–9.8 5.4–11.4 12.7–25.0 0.4–17.1 7.4–8.4
Notes: Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 21: Numbers and age-specific rates of interval cancers in women screened during 1998, 1999 
and 2000, subsequent screening rounds, 13–24 months, states and territories 
Age group 
Number/ 
rate NSW Vic Qld WA SA Tas ACT NT Australia
40–49 Number n.a. 24 79 15 14 14 5 0 n.a.
 Rate n.a. 12.9 13.0 9.4 10.1 15.9 9.8 0.0 n.a.
50–59 Number n.a. 216 180 69 79 32 19 5 n.a.
 Rate n.a. 12.3 16.0 11.6 12.8 16.1 14.7 13.9 n.a.
60–69 Number n.a. 203 131 56 70 10 5 2 n.a.
 Rate n.a. 13.8 15.9 12.7 13.3 6.6 6.9 14.7 n.a.
70+ Number n.a. 67 63 8 12 3 2 3 n.a.
 Rate n.a. 9.8 13.3 12.1 10.4 13.2 18.3 64.5 n.a.
Ages 40+ Number n.a. 510 453 148 175 59 31 10 n.a.
 Crude rate n.a. 12.4 14.9 11.7 12.5 12.8 11.8 14.5 n.a.
 ASR(A) n.a. 12.5 15.0 11.5 12.1 13.0 12.0 17.5 n.a.
 95% CI n.a. 11.2–14.0 13.6–16.4 9.6–13.7 10.2–14.1 9.7–17.1 7.6–17.6 7.7–33.4 n.a.
Ages 50–69 Number n.a. 419 311 125 149 42 24 7 n.a.
 Crude rate n.a. 13.0 15.9 12.1 13.0 12.0 11.9 14.1 n.a.
 ASR(A) n.a. 12.9 15.9 12.0 13.0 12.1 11.4 14.2 n.a.
 95% CI n.a. 11.7–14.2 14.2–17.8 10.0–14.4 11.0–15.2 8.7–16.4 7.3–17.1 5.3–30.1 n.a.
n.a.  Not available. 
Notes 
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
2. New South Wales data were unavailable at the time of publication. 
Source: AIHW analysis of BreastScreen Australia data. 
  69 
 
 
 
Table 22: Numbers and age-specific rates of interval cancers in women screened during 1998, 1999 
and 2000, subsequent screening rounds, 0–24 months, states and territories 
Age group 
Number/ 
rate NSW Vic Qld WA SA Tas ACT NT Australia
40–49 Number n.a. 37 134 36 32 18 8 1 n.a.
 Rate n.a. 9.9 10.6 10.0 10.7 9.7 9.2 3.3 n.a.
50–59 Number n.a. 354 280 117 140 51 43 6 n.a.
 Rate n.a. 10.1 12.1 9.1 11.0 12.4 16.5 8.3 n.a.
60–69 Number n.a. 310 194 89 103 21 18 3 n.a.
 Rate n.a. 10.5 11.7 9.2 9.6 6.7 12.4 10.9 n.a.
70+ Number n.a. 104 106 13 18 6 4 3 n.a.
 Rate n.a. 7.6 11.1 8.8 7.5 12.6 18.3 32.1 n.a.
Ages 40+ Number n.a. 805 714 255 293 96 73 13 n.a.
 Crude rate n.a. 9.8 11.5 9.2 10.2 10.0 14.2 9.3 n.a.
 ASR(A) n.a. 9.8 11.5 9.3 10.1 10.3 14.1 10.9 n.a.
 95% CI n.a. 9.0–10.7 10.7–12.4 8.1–10.6 8.9–11.4 8.2–12.7 10.7–18.1 5.5–19.3 n.a.
Ages 50–69 Number n.a. 664 474 206 243 72 61 9 n.a.
 Crude rate n.a. 10.3 11.9 9.1 10.4 9.9 15.0 9.0 n.a.
 ASR(A) n.a. 10.2 11.9 9.1 10.4 10.0 14.8 9.4 n.a.
 95% CI n.a. 9.5–11.1 10.9–13.0 7.9–10.5 9.1–11.8 7.8–12.6 11.3–19.0 4.0–18.2 n.a.
n.a.  Not available. 
Notes 
1. Rates are the number of interval cancers detected per 10,000 women-years and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
2. New South Wales data were unavailable at the time of publication. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 3b: Program sensitivity  
Table 23: Program sensitivity rates for women screened during 1998, 1999 and 2000, first screening 
round, 0–12 months, states and territories 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–49 75.7 79.3 85.7 81.1 70.2 75.0 70.0 75.0 79.1
50–59 87.9 85.7 86.8 90.6 84.2 88.0 94.7 83.3 86.9
60–69 92.1 95.2 92.7 92.7 95.2 80.0 90.0 100.0 92.9
70+ 90.2 95.0 96.8 95.8 100.0 100.0 100.0 100.0 94.3
Ages 40+              
Crude rate 86.7 88.2 90.0 89.0 86.2 85.7 88.1 84.0 88.0
ASR(A) 86.8 88.2 89.4 89.9 86.3 84.6 88.9 88.3 87.9
95% CI 80.9–93.1 80.8–96.0 83.0–96.2 76.3–100.0 75.3–98.5 63.3–100.0 61.8–100.0 50.0–100.0 84.5–91.4
Ages 50–69              
Crude rate 89.4 88.5 89.4 91.4 87.9 85.0 93.1 86.7 89.1
ASR(A) 89.6 89.7 89.2 91.5 88.7 84.7 92.8 90.3 89.4
95% CI 83.7–96.0 82.0–97.9 83.3–95.5 77.9–100.0 77.2–100.0 64.7–100.0 63.6–100.0 44.1–100.0 86.1–92.9
Notes: Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-
standardised to the population of women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 24: Program sensitivity rates for women screened during years 1998, 1999 and 2000, first 
screening round, 0–24 months, states and territories 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–49 n.a. 59.9 63.3 81.1 48.5 60.0 77.8 77.8 n.a.
50–59 n.a. 68.9 68.8 82.9 68.7 73.3 75.0 66.7 n.a.
60–69 n.a. 81.0 78.1 88.4 89.4 63.2 90.0 100.0 n.a.
70+ n.a. 88.5 91.6 92.0 97.0 100.0 75.0 100.0 n.a.
Ages 40+            
Crude rate n.a. 72.7 73.7 84.8 71.7 72.0 78.7 75.9 n.a.
ASR(A) n.a. 72.8 73.1 85.2 73.8 71.1 79.7 82.4 n.a.
95% CI n.a. 66.7–79.2 67.9–78.6 72.4–99.6 64.3–84.3 53.3–92.8 55.4–100.0 45.7–100.0 n.a.
Ages 50–69            
Crude rate n.a. 72.3 72.8 85.0 75.1 69.4 79.4 72.2 n.a.
ASR(A) n.a. 73.9 72.7 85.1 77.3 69.1 81.2 80.5 n.a.
95% CI n.a. 67.3–81.0 67.6–78.1 72.2–100.0 66.4–89.6 52.2–91.0 54.9–100.0 34.4–100.0 n.a.
n.a.  Not available. 
Notes 
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-
standardised to the population of women attending a BreastScreen Australia service in 1998. 
2. New South Wales data were unavailable at the time of publication. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 25: Program sensitivity rates for women screened during 1998, 1999 and 2000, subsequent 
screening rounds, 0–12 months, states and territories 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–49 67.9 78.0 71.6 63.2 70.5 81.0 75.0 75.0 70.4
50–59 80.4 80.8 80.2 83.8 80.4 79.3 72.7 93.3 80.6
60–69 84.7 87.8 87.4 89.8 89.4 86.3 72.3 85.7 86.8
70+ 90.5 91.9 88.1 92.5 92.8 87.0 81.8 100.0 90.5
Ages 40+              
Crude rate 83.4 86.0 83.3 85.6 84.6 82.9 73.4 90.3 84.2
ASR(A) 80.3 83.5 81.4 82.3 82.4 82.5 74.2 88.2 81.4
95% CI 76.7–84.0 77.9–89.4 76.8–86.2 75.2–89.7 75.5–89.7 70.0–96.5 59.4–91.3 57.4–100.0 79.3–83.6
Ages 50–69              
Crude rate 82.6 84.6 83.8 86.9 84.9 82.6 72.6 90.9 83.8
ASR(A) 82.2 83.7 83.2 86.3 84.1 82.2 72.6 90.2 83.2
95% CI 79.5–85.0 80.7–86.8 79.4–87.2 80.3–92.6 78.4–90.2 71.6–94.2 59.1–88.2 61.0–100.0 81.6–84.8
Notes: Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-
standardised to the population of women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 26: Program sensitivity rates for women screened during 1998, 1999 and 2000, subsequent 
screening rounds, 0–24 months, states and territories 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–49 n.a. 55.4 50.9 70.6 57.3 50.0 64.3 75.0 n.a.
50–59 n.a. 62.1 59.2 78.2 64.1 61.3 77.1 93.3 n.a.
60–69 n.a. 71.3 69.2 83.8 73.0 80.2 87.2 85.7 n.a.
70+ n.a. 80.2 75.0 88.6 81.1 76.9 81.8 100.0 n.a.
Ages 40+            
Crude rate n.a. 69.3 64.5 81.1 68.9 67.5 78.9 90.3 n.a.
ASR(A) n.a. 65.5 62.2 79.5 67.3 66.2 77.8 88.2 n.a.
95% CI n.a. 61.3–69.8 58.7–65.8 72.4–87.0 61.6–73.2 56.6–76.9 63.0–94.8 57.4–100.0 n.a.
Ages 50–69            
Crude rate n.a. 67.0 64.0 81.1 68.5 69.3 80.3 90.9 n.a.
ASR(A) n.a. 65.9 63.4 80.5 67.8 69.2 81.3 90.2 n.a.
95% CI n.a. 63.4–68.5 60.3–66.6 74.9–86.5 63.0–72.9 59.5–80.1 66.3–98.7 61.0–100.0 n.a.
n.a.  Not available. 
Notes 
1. Rates are the number of screen-detected cancers as a percentage of all cancers (screen-detected and interval cancers) and age-
standardised to the population of women attending a BreastScreen Australia service in 1998. 
2. New South Wales data were unavailable at the time of publication. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 4: Ductal carcinoma in situ 
Table 27: Number of women screened and cases of DCIS detected in these women by age, states 
and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–49 Screened 60,395 16,193 44,016 11,478 9,744 4,381 1,658 1,032 148,897
 Cases 35 16 24 15 7 3 0 0 100
50–59 Screened 105,764 84,047 68,712 32,463 32,081 9,353 6,367 2,131 340,918
 Cases 100 70 62 50 41 9 10 3 345
60–69 Screened 75,621 59,055 44,235 21,622 21,129 6,467 3,289 737 232,155
 Cases 77 63 48 45 16 5 4 0 258
70+ Screened 52,247 28,419 20,201 4,130 5,617 1,988 479 261 113,342
 Cases 64 28 20 11 18 5 0 0 146
Ages 40+ Screened 294,027 187,714 177,164 69,693 68,571 22,189 11,793 4,161 835,312
 Cases 276 177 154 121 82 22 14 3 849
Ages 50–69 Screened 181,385 143,102 112,947 54,085 53,210 15,820 9,656 2,868 573,073
 Cases 177 133 110 95 57 14 14 3 603
Source: AIHW analysis of BreastScreen Australia data. 
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Table 28: Age-specific rate of DCIS detected in women screened, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
40–49 5.8 9.9 5.5 13.1 7.2 6.8 0.0 0.0 6.7
50–59 9.5 8.3 9.0 15.4 12.8 9.6 15.7 14.1 10.1
60–69 10.2 10.7 10.9 20.8 7.6 7.7 12.2 0.0 11.1
70+ 12.2 9.9 9.9 26.6 32.0 25.2 0.0 0.0 12.9
Ages 40+      
Crude rate 9.4 9.4 8.7 17.4 12.0 9.9 11.9 7.2 10.2
ASR(A) 9.2 9.5 8.9 17.8 12.6 10.5 9.5 5.5 10.0
95% CI 8.2–10.4 8.0–11.1 7.5–10.4 14.6–21.5 9.9–15.7 6.5–15.9 5.1–16.0 1.1–16.1 9.4–10.7
Ages 50–69      
Crude rate 9.8 9.3 9.7 17.6 10.7 8.8 14.5 10.5 10.5
ASR(A) 9.8 9.3 9.8 17.7 10.6 8.8 14.2 8.2 10.5
95% CI 8.4–11.3 7.8–11.0 8.0–11.8 14.3–21.6 8.0–13.8 4.8–14.8 7.7–24.0 1.7–24.0 9.7–11.4
Note: Rates are the number of cases of DCIS per 10,000 women screened and age-standardised to the population of women attending a 
BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 5: Recall to assessment rate 
Table 29: Numbers of women screened and women recalled for assessment by age, mammographic 
reasons, first screening round, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 13,404 4,758 10,296 2,210 1,904 821 53 191 33,637
 Recalled 944 374 876 246 75 79 5 11 2,610
45–49 Screened 10,514 5,672 6,227 2,763 2,077 605 71 218 28,147
 Recalled 864 499 684 331 113 60 6 11 2,568
50–54 Screened 13,400 12,430 6,946 5,564 4,027 638 652 319 43,976
 Recalled 1,180 1,169 728 635 248 85 60 14 4,119
55–59 Screened 6,378 2,853 3,231 1,313 785 299 225 86 15,170
 Recalled 569 227 309 106 50 26 18 6 1,311
60–64 Screened 4,190 1,949 2,261 851 380 184 118 44 9,977
 Recalled 340 155 218 96 26 25 7 4 871
65–69 Screened 3,027 1,459 1,552 541 229 108 61 26 7,003
 Recalled 260 118 133 55 16 14 3 0 599
70–74 Screened 1,708 843 801 168 113 38 18 16 3,705
 Recalled 128 58 64 13 11 5 3 1 283
75–79 Screened 1,088 494 490 113 114 37 25 8 2,369
 Recalled 98 22 50 10 6 3 0 0 189
80–84 Screened 436 191 156 49 64 11 6 3 916
 Recalled 33 9 19 5 6 1 0 1 74
85+ Screened 118 49 53 17 8 4 0 0 249
 Recalled 18 6 6 3 1 1 0 0 35
Ages 40+ Screened 54,263 30,698 32,013 13,589 9,701 2,745 1,229 911 145,149
 Recalled 4,434 2,637 3,087 1,500 552 299 102 48 12,659
Ages 50–69 Screened 26,995 18,691 13,990 8,269 5,421 1,229 1,056 475 76,126
 Recalled 2,349 1,669 1,388 892 340 150 88 24 6,900
Source: BreastScreen Australia. 
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Table 30: Age-specific and age-standardised recall to assessment rates, mammographic reasons, 
first screening round, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–44 7.0 7.9 8.5 11.1 3.9 9.6 9.4 5.8 7.8
45–49 8.2 8.8 11.0 12.0 5.4 9.9 8.5 5.0 9.1
50–54 8.8 9.4 10.5 11.4 6.2 13.3 9.2 4.4 9.4
55–59 8.9 8.0 9.6 8.1 6.4 8.7 8.0 7.0 8.6
60–64 8.1 8.0 9.6 11.3 6.8 13.6 5.9 9.1 8.7
65–69 8.6 8.1 8.6 10.2 7.0 13.0 4.9 0.0 8.6
70–74 7.5 6.9 8.0 7.7 9.7 13.2 16.7 6.3 7.6
75–79 9.0 4.5 10.2 8.8 5.3 8.1 0.0 0.0 8.0
80–84 7.6 4.7 12.2 10.2 9.4 9.1 0.0 33.3 8.1
85+ 15.3 12.2 11.3 17.6 12.5 25.0 . . . . 14.1
Ages 40+              
Crude rate 8.2 8.6 9.6 11.0 5.7 10.9 8.3 5.3 8.7
ASR(A) 8.4 8.2 9.7 10.3 6.4 11.6 8.1 5.4 8.7
95% CI 8.1–8.7 7.8–8.6 9.2–10.1 9.6–11.1 5.6–7.3 9.8–13.5 5.9–10.7 3.4–7.9 8.5–8.9
Ages 50–69              
Crude rate 8.7 8.9 9.9 10.8 6.3 12.2 8.3 5.1 9.1
ASR(A) 8.6 8.5 9.7 10.3 6.5 12.1 7.3 5.2 8.9
95% CI 8.3–9.0 7.9–9.0 9.1–10.2 9.4–11.2 5.5–7.6 10.0–14.5 5.5–9.4 2.9–8.4 8.6–9.1
. . Not applicable—no women in this age group screened in 2002. 
Note: Rates are the number of women recalled for assessment as the percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 31: Numbers of women screened and women recalled for assessment by age, mammographic 
reasons, subsequent screening rounds, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 8,974 970 7,532 1,333 1,259 630 266 130 21,094
 Recalled 387 48 359 60 38 41 16 2 951
45–49 Screened 27,503 4,793 19,961 5,172 4,504 2,325 1,268 493 66,019
 Recalled 1,268 294 1,073 241 108 151 81 22 3,238
50–54 Screened 41,214 32,554 29,250 12,047 13,385 4,052 2,808 922 136,232
 Recalled 1,760 1,362 1,400 488 335 222 154 28 5,749
55–59 Screened 44,773 36,210 29,285 13,539 13,884 4,364 2,682 804 145,541
 Recalled 1,878 1,389 1,390 494 303 238 115 34 5,841
60–64 Screened 37,150 30,222 22,610 11,100 11,025 3,368 1,797 431 117,703
 Recalled 1,598 1,136 1,070 399 282 162 96 13 4,756
65–69 Screened 31,253 25,425 17,812 9,130 9,495 2,807 1,313 236 97,471
 Recalled 1,236 911 891 331 287 153 56 9 3,874
70–74 Screened 25,852 20,856 14,114 2,538 3,350 1,525 279 143 68,657
 Recalled 995 703 624 103 95 74 11 6 2,611
75–79 Screened 16,369 5,234 3,607 975 1,611 295 117 56 28,264
 Recalled 599 188 167 38 50 11 4 3 1,060
80–84 Screened 5,506 652 800 234 319 72 30 30 7,643
 Recalled 179 26 40 9 13 2 2 0 271
85+ Screened 1,170 100 180 36 38 6 4 5 1,539
 Recalled 47 5 10 3 2 0 1 0 68
Ages 40+ Screened 239,764 157,016 145,151 56,104 58,870 19,444 10,564 3,250 690,163
 Recalled 9,947 6,062 7,024 2,166 1,513 1,054 536 117 28,419
Ages 50–69 Screened 154,390 124,411 98,957 45,816 47,789 14,591 8,600 2,393 496,947
 Recalled 6,472 4,798 4,751 1,712 1,207 775 421 84 20,220
 Source: BreastScreen Australia. 
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Table 32: Age-specific and age-standardised recall to assessment rates, mammographic reasons, 
subsequent screening rounds, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–44 4.3 4.9 4.8 4.5 3.0 6.5 6.0 1.5 4.5
45–49 4.6 6.1 5.4 4.7 2.4 6.5 6.4 4.5 4.9
50–54 4.3 4.2 4.8 4.1 2.5 5.5 5.5 3.0 4.2
55–59 4.2 3.8 4.7 3.6 2.2 5.5 4.3 4.2 4.0
60–64 4.3 3.8 4.7 3.6 2.6 4.8 5.3 3.0 4.0
65–69 4.0 3.6 5.0 3.6 3.0 5.5 4.3 3.8 4.0
70–74 3.8 3.4 4.4 4.1 2.8 4.9 3.9 4.2 3.8
75–79 3.7 3.6 4.6 3.9 3.1 3.7 3.4 5.4 3.8
80–84 3.3 4.0 5.0 3.8 4.1 2.8 6.7 0.0 3.5
85+ 4.0 5.0 5.6 8.3 5.3 0.0 25.0 0.0 4.4
Ages 40+              
Crude rate 4.1 3.9 4.8 3.9 2.6 5.4 5.1 3.6 4.1
ASR(A) 4.2 4.2 4.8 4.0 2.6 5.4 5.1 3.5 4.2
95% CI 4.1–4.3 4.0–4.4 4.7–5.0 3.8–4.2 2.5–2.8 5.1–5.8 4.6–5.6 2.9–4.3 4.1–4.2
Ages 50–69              
Crude rate 4.2 3.9 4.8 3.7 2.5 5.3 4.9 3.5 4.1
ASR(A) 4.2 3.9 4.8 3.8 2.5 5.3 4.9 3.5 4.1
95% CI 4.1–4.3 3.8–4.0 4.7–4.9 3.6–3.9 2.4–2.7 4.9–5.7 4.4–5.4 2.7–4.4 4.0–4.1
Note: Rates are the number of women recalled for assessment as the percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 33: Numbers of women screened and women recalled for assessment by age, other reasons 
only, first screening round, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 13,404 4,758 10,296 2,210 1,904 821 53 191 33,637
 Recalled 24 131 205 29 0 0 0 0 389
45–49 Screened 10,514 5,672 6,227 2,763 2,077 605 71 218 28,147
 Recalled 12 124 118 46 0 0 0 0 300
50–54 Screened 13,400 12,430 6,946 5,564 4,027 638 652 319 43,976
 Recalled 11 198 77 41 0 0 0 0 327
55–59 Screened 6,378 2,853 3,231 1,313 785 299 225 86 15,170
 Recalled 0 55 42 10 0 0 0 0 107
60–64 Screened 4,190 1,949 2,261 851 380 184 118 44 9,977
 Recalled 1 28 15 5 0 0 0 0 49
65–69 Screened 3,027 1,459 1,552 541 229 108 61 26 7,003
 Recalled 0 26 15 3 0 0 0 0 44
70–74 Screened 1,708 843 801 168 113 38 18 16 3,705
 Recalled 2 5 8 1 0 0 0 0 16
75–79 Screened 1,088 494 490 113 114 37 25 8 2,369
 Recalled 0 5 5 1 0 0 0 0 11
80–84 Screened 436 191 156 49 64 11 6 3 916
 Recalled 2 2 4 0 0 0 0 0 8
85+ Screened 118 49 53 17 8 4 0 0 249
 Recalled 0 0 0 0 0 0 0 0 0
Ages 40+ Screened 54,263 30,698 32,013 13,589 9,701 2,745 1,229 911 145,149
 Recalled 52 574 489 136 0 0 0 0 1,251
Ages 50–69 Screened 26,995 18,691 13,990 8,269 5,421 1,229 1,056 475 76,126
 Recalled 12 307 149 59 0 0 0 0 527
Source: BreastScreen Australia. 
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Table 34: Age-specific and age-standardised recall to assessment rates, first screening round, other 
reasons only, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–44 0.2 2.8 2.0 1.3 0.0 0.0 0.0 0.0 1.2
45–49 0.1 2.2 1.9 1.7 0.0 0.0 0.0 0.0 1.1
50–54 0.1 1.6 1.1 0.7 0.0 0.0 0.0 0.0 0.7
55–59 0.0 1.9 1.3 0.8 0.0 0.0 0.0 0.0 0.7
60–64 0.0 1.4 0.7 0.6 0.0 0.0 0.0 0.0 0.5
65–69 0.0 1.8 1.0 0.6 0.0 0.0 0.0 0.0 0.6
70–74 0.1 0.6 1.0 0.6 0.0 0.0 0.0 0.0 0.4
75–79 0.0 1.0 1.0 0.9 0.0 0.0 0.0 0.0 0.5
80–84 0.5 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.9
85+ 0.0 0.0 0.0 0.0 0.0 0.0 . . . . 0.0
Ages 40+              
Crude rate 0.1 1.9 1.5 1.0 0.0 0.0 0.0 0.0 0.9
ASR(A) 0.1 1.7 1.2 0.8 0.0 0.0 0.0 0.0 0.7
95% CI 0.0–0.1 1.5–1.9 1.1–1.4 0.7–1.1 . . . . . . . . 0.7–0.8
Ages 50–69              
Crude rate 0.0 1.6 1.1 0.7 0.0 0.0 0.0 0.0 0.7
ASR(A) 0.0 1.7 1.0 0.7 0.0 0.0 0.0 0.0 0.7
95% CI 0.0–0.1 1.5–1.9 0.9–1.2 0.5–0.9 . . . . . . . . 0.6–0.7
. .  Not applicable. 
Note: Rates are the number of women recalled for assessment as the percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 35: Numbers of women screened and women recalled for assessment by age, other reasons 
only, subsequent screening rounds, states and territories, 2002 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 8,974 970 7,532 1,333 1,259 630 266 130 21,094
 Recalled 10 19 120 11 0 0 0 0 160
45–49 Screened 27,503 4,793 19,961 5,172 4,504 2,325 1,268 493 66,019
 Recalled 15 80 259 37 0 0 0 0 391
50–54 Screened 41,214 32,554 29,250 12,047 13,385 4,052 2,808 922 136,232
 Recalled 26 381 286 59 0 0 0 0 752
55–59 Screened 44,773 36,210 29,285 13,539 13,884 4,364 2,682 804 145,541
 Recalled 19 390 243 53 0 0 0 0 705
60–64 Screened 37,150 30,222 22,610 11,100 11,025 3,368 1,797 431 117,703
 Recalled 15 208 150 28 0 0 1 0 402
65–69 Screened 31,253 25,425 17,812 9,130 9,495 2,807 1,313 236 97,471
 Recalled 15 107 130 26 0 0 0 0 278
70–74 Screened 25,852 20,856 14,114 2,538 3,350 1,525 279 143 68,657
 Recalled 4 85 81 6 0 0 0 0 176
75–79 Screened 16,369 5,234 3,607 975 1,611 295 117 56 28,264
 Recalled 4 23 45 3 0 0 0 0 75
80–84 Screened 5,506 652 800 234 319 72 30 30 7,643
 Recalled 2 5 16 1 0 0 0 0 24
85+ Screened 1,170 100 180 36 38 6 4 5 1,539
 Recalled 0 1 4 1 0 0 0 0 6
Ages 40+ Screened 239,764 157,016 145,151 56,104 58,870 19,444 10,564 3,250 690,163
 Recalled 110 1,299 1,334 225 0 0 1 0 2,969
Ages 50–69 Screened 154,390 124,411 98,957 45,816 47,789 14,591 8,600 2,393 496,947
 Recalled 75 1,086 809 166 0 0 1 0 2,137
 Source: BreastScreen Australia. 
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Table 36: Age-specific and age-standardised recall to assessment rates, other reasons only, 
subsequent screening rounds, states and territories, 2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–44 0.1 2.0 1.6 0.8 0.0 0.0 0.0 0.0 0.8
45–49 0.1 1.7 1.3 0.7 0.0 0.0 0.0 0.0 0.6
50–54 0.1 1.2 1.0 0.5 0.0 0.0 0.0 0.0 0.6
55–59 0.0 1.1 0.8 0.4 0.0 0.0 0.0 0.0 0.5
60–64 0.0 0.7 0.7 0.3 0.0 0.0 0.1 0.0 0.3
65–69 0.0 0.4 0.7 0.3 0.0 0.0 0.0 0.0 0.3
70–74 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.3
75–79 0.0 0.4 1.2 0.3 0.0 0.0 0.0 0.0 0.3
80–84 0.0 0.8 2.0 0.4 0.0 0.0 0.0 0.0 0.3
85+ 0.0 1.0 2.2 2.8 0.0 0.0 0.0 0.0 0.4
Ages 40+              
Crude rate 0.0 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.4
ASR(A) 0.1 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.5
95% CI 0.0–0.1 0.9–1.1 0.9–1.0 0.4–0.5 . . . . . . . . 0.4–0.5
Ages 50–69              
Crude rate 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.4
ASR(A) 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.4
95% CI 0.0–0.1 0.8–0.9 0.8–0.9 0.3–0.4 . . . . 0.0–0.1 . . 0.4–0.5
. .  Not applicable. 
Note: Rates are the number of women recalled for assessment as the percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data.
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Indicator 6: Rescreen rate 
Table 37: Number of women screened during 2000 and number of those women who returned for 
screening within 27 months by age, first screening round, states and territories 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 12,586 4,503 9,192 2,246 2,337 755 525 235 32,379
 Returned 7,771 696 6,360 1,278 1,307 532 233 129 18,306
45–49 Screened 10,342 5,493 6,394 2,937 2,488 586 583 238 29,061
 Returned 6,346 2,262 4,280 1,778 1,565 380 291 143 17,045
50–54 Screened 12,156 12,300 8,439 3,199 5,184 792 656 444 43,170
 Returned 7,666 8,670 5,784 1,864 3,561 543 370 252 28,710
55–59 Screened 5,179 3,147 4,269 915 1,088 339 198 117 15,252
 Returned 3,204 2,061 3,042 542 698 224 118 59 9,948
60–64 Screened 3,986 2,434 3,136 702 626 221 126 55 11,286
 Returned 2,516 1,645 2,300 448 430 153 69 24 7,585
65–69 Screened 2,822 1,733 2,414 450 523 154 82 29 8,207
 Returned 1,763 1,125 1,767 217 224 111 33 14 5,254
70–74 Screened 1,734 850 1,291 232 239 78 41 15 4,480
 Returned 1,079 471 764 50 41 46 6 2 2,459
75–79 Screened 1,242 605 745 169 237 59 23 7 3,087
 Returned 733 41 98 23 40 11 2 3 951
80–84 Screened 457 224 234 46 65 17 11 2 1,056
 Returned 240 11 28 3 6 2 1 1 292
85+ Screened 128 56 78 9 13 10 6 1 301
 Returned 44 2 12 0 0 0 0 1 59
Ages 40+ Screened 50,632 31,345 36,192 10,905 12,800 3,011 2,251 1,143 148,279
 Returned 31,362 16,984 24,435 6,203 7,872 2,002 1,123 628 90,609
Ages 50–67 Screened 23,140 19,025 17,353 5,103 7,211 1,506 1,038 639 75,015
 Returned 14,527 13,121 12,241 3,032 4,882 1,031 586 344 49,764
Source: BreastScreen Australia. 
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Table 38: Age-specific and age-standardised rescreen rates for women screened during 2000, first 
screening round, states and territories 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–44 61.7 15.5 69.2 56.9 55.9 70.5 44.4 54.9 56.5
45–49 61.4 41.2 66.9 60.5 62.9 64.8 49.9 60.1 58.7
50–54 63.1 70.5 68.5 58.3 68.7 68.6 56.4 56.8 66.5
55–59 61.9 65.5 71.3 59.2 64.2 66.1 59.6 50.4 65.2
60–64 63.1 67.6 73.3 63.8 68.7 69.2 54.8 43.6 67.2
65–69 62.5 64.9 73.2 48.2 42.8 72.1 40.2 48.3 64.0
70–74 62.2 55.4 59.2 21.6 17.2 59.0 14.6 13.3 54.9
75–79 59.0 6.8 13.2 13.6 16.9 18.6 8.7 42.9 30.8
80–84 52.5 4.9 12.0 6.5 9.2 11.8 9.1 50.0 27.7
85+ 34.4 3.6 15.4 0.0 0.0 0.0 0.0 0.0 19.6
Ages 40+              
Crude rate 61.9 54.2 67.5 56.9 61.5 66.5 49.9 54.9 61.1
ASR(A) 62.1 56.4 67.1 53.1 56.3 65.4 47.4 48.7 61.8
95% CI 61.3–63.0 55.4–57.5 66.1–68.1 51.4–54.9 54.6–58.0 61.9–69.0 43.7–51.2 43.1–54.6 61.3–62.3
Ages 50–67              
Crude rate 62.8 69.0 70.5 59.4 67.7 68.5 56.5 53.8 66.3
ASR(A) 62.7 67.7 71.1 60.3 66.5 68.5 56.1 49.6 66.3
95% CI 61.4–64.0 65.8–69.7 69.6–72.6 57.0–63.8 62.7–70.4 63.1–74.1 48.9–63.7 39.2–60.8 65.5–67.1
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 39: Number of women screened during 2000 and number of those women who returned for 
screening within 27 months by age, second screening round, states and territories 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 8,014 939 5,641 1,092 1,015 602 238 104 17,645
 Returned 5,870 346 4,430 787 765 493 152 73 12,916
45–49 Screened 11,133 3,105 7,335 2,529 2,069 901 478 213 27,763
 Returned 7,946 1,574 5,679 1,800 1,588 699 313 149 19,748
50–54 Screened 14,595 17,935 11,191 3,867 4,634 1,244 803 476 54,745
 Returned 10,590 14,132 8,840 2,719 3,730 973 544 320 41,848
55–59 Screened 8,010 4,338 8,415 1,887 1,910 648 268 263 25,739
 Returned 5,660 3,151 6,733 1,273 1,495 499 152 155 19,118
60–64 Screened 6,095 2,862 6,316 1,403 1,084 405 180 124 18,469
 Returned 4,485 2,133 5,183 1,000 824 298 110 83 14,116
65–69 Screened 4,614 2,107 5,254 972 852 336 108 92 14,335
 Returned 3,318 1,550 4,236 491 482 263 50 55 10,445
70–74 Screened 3,331 1,428 3,392 333 309 96 36 53 8,978
 Returned 2,268 883 2,327 74 93 57 5 30 5,737
75–79 Screened 2,026 538 1,239 214 310 72 32 21 4,452
 Returned 1,335 71 183 40 86 15 6 14 1,750
80–84 Screened 646 223 387 41 85 19 7 5 1,413
 Returned 389 27 48 9 17 4 1 3 498
85+ Screened 141 41 121 9 9 3 0 1 325
 Returned 54 4 7 2 1 0 0 0 68
Ages 40+ Screened 58,605 33,516 49,291 12,347 12,277 4,326 2,150 1,352 173,864
 Returned 41,915 23,871 37,666 8,195 9,081 3,301 1,333 882 126,244
Ages 50–67 Screened 31,577 26,465 29,037 7,755 8,180 2,633 1,318 922 107,887
 Returned 22,812 20,398 23,276 5,406 6,461 2,033 848 595 81,829
Source: BreastScreen Australia. 
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Table 40: Age-specific and age-standardised rescreen rates in women screened during 2000, second 
screening round, states and territories 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–44 73.2 36.8 78.5 72.1 75.4 81.9 63.9 70.2 73.2
45–49 71.4 50.7 77.4 71.2 76.8 77.6 65.5 70.0 71.1
50–54 72.6 78.8 79.0 70.3 80.5 78.2 67.7 67.2 76.4
55–59 70.7 72.6 80.0 67.5 78.3 77.0 56.7 58.9 74.3
60–64 73.6 74.5 82.1 71.3 76.0 73.6 61.1 66.9 76.4
65–69 71.9 73.6 80.6 50.5 56.6 78.3 46.3 59.8 72.9
70–74 68.1 61.8 68.6 22.2 30.1 59.4 13.9 56.6 63.9
75–79 65.9 13.2 14.8 18.7 27.7 20.8 18.8 66.7 39.3
80–84 60.2 12.1 12.4 22.0 20.0 21.1 14.3 60.0 35.2
85+ 38.3 9.8 5.8 22.2 11.1 0.0 . . 100.0 20.9
Ages 40+              
Crude rate 71.5 71.2 76.4 66.4 74.0 76.3 62.0 65.2 72.6
ASR(A) 71.5 65.4 76.1 61.5 69.0 73.6 54.9 64.3 72.0
95% CI 70.7–72.2 64.3–66.4 75.3–76.8 60.1–63.0 67.4–70.6 70.7–76.5 51.4–58.5 59.7–69.1 71.6–72.4
Ages 50–67              
Crude rate 72.2 77.1 80.2 69.7 79.0 77.2 64.3 64.5 75.8
ASR(A) 72.2 75.4 80.3 69.6 78.0 76.8 62.4 64.3 75.7
95% CI 71.1–73.3 73.5–77.3 79.2–81.3 67.4–71.9 75.4–80.7 72.7–81.0 56.1–69.1 57.6–71.3 75.1–76.3
. .  Not applicable—no women in this age group screened in 2000. 
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Table 41: Number of women screened during 2000 and number of those women who returned for 
screening within 27 months by age, third and subsequent screening rounds, states and territories 
Age group Number NSW Vic Qld WA SA Tas ACT NT Australia
40–44 Screened 1,962 132 1,726 396 228 219 60 37 4,760
 Returned 1,591 74 1,474 337 191 182 53 29 3,931
45–49 Screened 15,567 2,038 10,387 2,622 2,384 1,775 906 224 35,903
 Returned 12,318 1,385 8,787 2,131 2,006 1,486 618 181 28,912
50–54 Screened 25,618 13,787 14,720 9,382 6,987 2,988 1,713 341 75,536
 Returned 20,720 11,516 12,614 7,531 6,111 2,527 1,283 272 62,574
55–59 Screened 32,329 26,086 14,629 10,099 9,194 3,056 1,837 331 97,561
 Returned 26,424 22,339 12,775 8,268 8,112 2,607 1,389 259 82,173
60–64 Screened 29,089 24,702 12,354 9,205 9,030 2,826 1,273 188 88,667
 Returned 24,073 21,478 10,879 7,724 8,103 2,430 996 148 75,831
65–69 Screened 25,242 21,337 10,108 7,637 7,529 2,331 864 102 75,150
 Returned 20,658 18,215 8,803 4,924 5,228 1,980 483 83 60,374
70–74 Screened 21,594 18,409 8,385 1,934 2,846 520 208 79 53,975
 Returned 17,245 12,800 6,189 918 1,551 391 59 56 39,209
75–79 Screened 11,241 4,287 4,293 598 779 147 59 28 21,432
 Returned 8,522 700 906 300 400 69 20 20 10,937
80–84 Screened 3,207 380 1,354 124 147 23 6 14 5,255
 Returned 2,127 103 252 58 66 7 1 11 2,625
85+ Screened 718 61 300 19 22 6 4 0 1,130
 Returned 353 10 50 7 8 1 0 0 429
Ages 40+ Screened 166,567 111,219 78,256 42,016 39,146 13,891 6,930 1,344 459,369
 Returned 134,031 88,620 62,729 32,198 31,776 11,680 4,902 1,059 366,995
Ages 50–67 Screened 102,246 77,609 47,956 33,425 29,858 11,201 5,382 923 308,600
 Returned 83,847 66,556 41,769 27,446 26,470 9,544 4,079 735 260,446
Source: BreastScreen Australia. 
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Table 42: Age-specific and age-standardised rescreen rates in women screened during 2000, third 
and subsequent screening rounds, states and territories 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
(Per cent) 
40–44 81.1 56.1 85.4 85.1 83.8 83.1 88.3 78.4 82.6
45–49 79.1 68.0 84.6 81.3 84.1 83.7 68.2 80.8 80.5
50–54 80.9 83.5 85.7 80.3 87.5 84.6 74.9 79.8 82.8
55–59 81.7 85.6 87.3 81.9 88.2 85.3 75.6 78.2 84.2
60–64 82.8 86.9 88.1 83.9 89.7 86.0 78.2 78.7 85.5
65–69 81.8 85.4 87.1 64.5 69.4 84.9 55.9 81.4 80.3
70–74 79.9 69.5 73.8 47.5 54.5 75.2 28.4 70.9 72.6
75–79 75.8 16.3 21.1 50.2 51.3 46.9 33.9 71.4 51.0
80–84 66.3 27.1 18.6 46.8 44.9 30.4 16.7 78.6 50.0
85+ 49.2 16.4 16.7 36.8 36.4 16.7 0.0 . . 38.0
Ages 40+              
Crude rate 80.5 79.7 80.2 76.6 81.2 84.1 70.7 78.8 79.9
ASR(A) 80.8 76.6 82.7 75.5 80.6 82.2 67.5 78.4 80.6
95% CI 80.3–81.3 75.4–77.8 82.0–83.4 74.4–76.6 79.3–81.9 80.5–84.0 64.9–70.2 73.3–83.7 80.3–81.0
Ages 50–67              
Crude rate 82.0 85.8 87.1 82.1 88.7 85.2 75.8 79.6 84.4
ASR(A) 81.8 85.3 87.0 81.9 88.4 85.2 75.7 80.3 84.2
95% CI 81.3–82.3 84.8–85.7 86.2–87.8 81.1–82.7 87.6–89.3 83.6–86.8 73.5–78.0 74.1–86.8 83.9–84.4
. .  Not applicable—no women screened in this age group in 2000. 
Note: Rates are the number of women attending for rescreening as a percentage of women screened and age-standardised to the population of 
women attending a BreastScreen Australia service in 1998. 
Source: AIHW analysis of BreastScreen Australia data. 
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Indicator 7a: Incidence of breast cancer 
Table 43: Number of new cases of breast cancer in women by age, Australia, 1987–2001 
Age 
group 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
0–4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5–9 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
10–14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 1 0 2 3 0 2 0
20–24 4 7 8 4 11 6 13 7 8 6 14 15 11 4 9
25–29 59 47 44 54 51 46 58 57 57 42 50 50 51 54 46
30–34 191 164 158 204 182 180 169 199 202 194 173 197 184 186 170
35–39 363 345 367 341 400 379 412 395 399 423 446 418 438 437 449
40–44 590 653 652 671 721 714 781 772 751 759 759 850 819 843 917
45–49 693 673 751 829 855 1,014 1,030 1,144 1,235 1,187 1,160 1,159 1,152 1,271 1,223
50–54 599 632 726 788 857 859 978 1,106 1,243 1,188 1,329 1,466 1,500 1,564 1,649
55–59 693 633 680 689 807 821 926 1,033 1,142 1,123 1,176 1,266 1,297 1,430 1,539
60–64 821 850 885 824 886 788 973 1,102 1,067 1,016 1,076 1,142 1,243 1,337 1,439
65–69 768 769 828 857 951 930 1,002 1,215 1,097 1,067 1,077 1,142 1,095 1,121 1,175
70–74 629 697 712 756 791 778 900 1,020 1,008 990 1,032 1,057 987 1,097 1,112
75–79 584 576 624 633 672 655 691 784 849 740 864 885 836 899 893
80–84 390 385 396 425 487 491 468 527 580 571 577 590 558 578 611
85+ 304 301 329 337 372 366 395 377 414 436 446 490 491 522 559
All 
ages 6,688 6,732 7,160 7,412 8,043 8,027 8,796 9,738 10,054 9,742 10,181 10,730 10,662 11,345 11,791
Ages 
50–69 2,881 2,884 3,119 3,158 3,501 3,398 3,879 4,456 4,549 4,394 4,658 5,016 5,135 5,452 5,802
Source: AIHW National Cancer Statistics Clearing House. 
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Table 44: Age-specific and age-standardised incidence rates for breast cancer in women, Australia, 
1987–2001 
Age 
group 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
0–4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
5–9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0
10–14 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
15–19 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.3 0.0
20–24 0.6 1.1 1.2 0.6 1.6 0.9 1.8 1.0 1.1 0.9 2.1 2.3 1.7 0.6 1.4
25–29 8.6 6.8 6.2 7.6 7.3 6.7 8.5 8.4 8.3 5.9 6.9 6.8 7.0 7.4 6.5
30–34 29.5 24.8 23.3 29.4 25.6 24.8 23.1 27.1 27.6 26.8 24.2 27.8 25.9 25.9 23.0
35–39 58.1 54.4 56.8 51.9 60.2 55.9 59.9 56.6 56.0 58.0 60.0 55.6 57.8 57.8 59.8
40–44 110.1 114.6 109.4 108.4 112.8 111.3 120.7 117.5 112.5 111.8 109.7 121.0 114.6 115.7 123.1
45–49 164.3 154.6 164.7 173.2 170.1 188.3 179.8 192.0 200.3 185.6 180.5 177.3 173.2 188.5 178.9
50–54 162.7 167.5 186.5 196.6 207.4 202.5 225.4 244.1 261.1 238.8 247.4 256.0 250.9 251.0 254.4
55–59 188.7 174.1 188.4 191.8 225.0 224.1 246.4 267.9 288.7 275.6 279.2 292.1 286.5 302.0 310.3
60–64 222.9 229.7 238.8 222.3 239.4 215.7 270.6 308.7 299.1 284.9 295.9 306.6 323.5 336.9 352.7
65–69 242.9 233.5 241.5 245.9 270.7 263.5 282.0 342.8 309.7 300.8 305.7 327.2 316.4 324.9 338.7
70–74 235.4 260.5 267.9 279.3 280.2 265.9 296.5 321.5 312.1 302.7 314.0 319.3 296.1 328.8 332.1
75–79 293.7 279.8 290.5 286.8 298.0 285.9 300.4 344.2 363.8 303.5 336.9 329.2 297.6 312.4 305.8
80–84 315.1 298.3 295.9 305.0 334.9 324.2 295.7 315.2 336.4 323.3 320.8 324.1 304.8 304.2 302.8
85+ 312.8 301.6 318.8 319.1 338.1 316.5 324.2 295.7 308.2 307.9 298.6 312.6 295.6 298.0 304.9
All Ages                             
Crude 
rate 82.1 81.3 85.0 86.7 92.8 91.4 99.2 108.6 110.7 105.9 109.3 113.9 111.9 117.6 120.5
ASR 91.2 89.6 93.4 94.8 100.4 98.2 105.4 114.0 115.7 109.2 111.3 114.6 111.3 115.6 117.2
Ages 50–69                      
Crude 
rate 202.9 200.2 213.1 213.5 234.5 225.2 254.4 287.5 287.5 271.8 278.2 290.3 288.3 296.5 305.5
ASR 196.9 194.5 208.1 209.7 230.3 222.0 250.8 282.0 285.3 269.6 276.7 289.2 287.7 296.2 305.4
Note: Rates are the number of cases of invasive cancers per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
Source: AIHW National Cancer Statistics Clearing House. 
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Table 45: Number of new cases of breast cancer in women by age, states and territories, 1998–2001 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
0–4 0 0 0 0 0 0 0 0 0
5–9 0 0 0 0 0 0 0 0 0
10–14 0 0 0 0 0 0 0 0 0
15–19 0 1 2 2 0 0 0 0 5
20–24 17 9 6 3 4 0 0 0 39
25–29 56 69 39 17 11 2 3 4 201
30–34 242 192 120 85 61 18 15 4 737
35–39 604 422 318 183 143 31 27 14 1,742
40–44 1,196 870 618 301 277 76 63 28 3,429
45–49 1,557 1,206 910 483 419 109 88 33 4,805
50–54 2,016 1,520 1,114 611 575 159 141 43 6,179
55–59 1,910 1,314 1,047 505 492 136 96 32 5,532
60–64 1,683 1,299 1,010 474 456 139 79 21 5,161
65–69 1,514 1,195 828 425 408 95 57 11 4,533
70–74 1,543 1,159 763 295 316 117 47 13 4,253
75–79 1,213 945 604 293 322 90 40 6 3,513
80–84 781 614 448 194 220 47 29 4 2,337
85+ 691 572 349 168 208 52 17 5 2,062
All ages 15,023 11,387 8,176 4,039 3,912 1,071 702 218 44,528
Ages 50–69 7,123 5,328 3,999 2,015 1,931 529 373 107 21,405
Source: AIHW National Cancer Statistics Clearing House. 
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Table 46: Age-specific and age-standardised incidence rates for breast cancer in women, states and 
territories, 1998–2001 
Age 
group NSW Vic Qld WA SA Tas ACT NT Australia
0–4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
5–9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
10–14 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
15–19 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.2
20–24 2.0 1.4 1.2 1.2 2.1 0.0 0.0 0.0 1.5
25–29 5.7 9.4 7.2 6.1 5.3 3.2 5.6 10.7 6.9
30–34 25.1 26.0 22.8 30.1 28.4 27.5 29.8 11.5 25.6
35–39 59.2 56.2 57.0 61.3 61.5 42.2 52.3 42.9 57.7
40–44 123.2 121.6 116.0 103.5 121.6 104.8 124.7 97.2 118.7
45–49 174.6 182.2 183.9 179.1 194.1 162.0 178.4 131.4 179.5
50–54 246.7 250.6 244.6 260.3 284.6 256.9 319.6 216.8 253.1
55–59 301.5 284.6 304.5 292.0 320.3 280.0 332.7 257.6 298.2
60–64 310.7 326.7 365.7 330.5 344.3 332.2 379.1 279.2 330.5
65–69 309.7 333.7 347.7 347.1 336.7 255.0 349.7 227.3 326.8
70–74 325.5 334.4 339.6 265.3 257.1 333.0 316.6 382.6 319.1
75–79 301.2 322.4 320.2 319.3 298.6 293.4 319.5 267.6 311.0
80–84 287.7 316.9 350.6 316.8 304.9 220.6 371.9 280.5 308.8
85+ 289.0 317.2 312.1 286.9 314.1 287.4 278.0 456.6 302.7
All ages             
Crude 
rate 115.5 119.0 115.4 108.7 128.8 112.0 110.6 59.1 116.0
ASR(A) 112.4 115.6 118.3 113.4 118.3 106.2 124.8 100.0 114.7
95% CI 110.6–114.3 113.4–117.7 115.8–120.9 109.9–116.9 114.6–122.1 99.9–112.7 115.6–134.5 85.0–116.6 113.7–115.8
Ages 50–69            
Crude 
rate 287.1 292.1 304.4 299.1 317.0 279.1 338.7 239.9 295.4
ASR(A) 286.3 290.9 305.0 299.3 316.2 278.9 341.3 242.9 294.9
95% CI 279.7–293.0 283.1–298.8 295.6–314.6 286.4–312.7 302.3–330.7 255.6–303.7 307.2–378.1 197.4–295.5 290.9–298.9
Note: Rates are the number of cases of invasive cancers per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
Source: AIHW National Cancer Statistics Clearing House. 
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Table 47: Number of new cases of breast cancer in women, by age and region, 1997–2001 
Age group Major cities Inner regional Outer regional Remote Very remote Australia
0–4 0 0 0 0 0 0
5–9 0 0 0 0 0 0
10–14 0 0 0 0 0 0
15–19 4 2 1 0 0 7
20–24 42 9 2 0 0 53
25–29 184 38 22 4 3 251
30–34 661 154 78 10 6 910
35–39 1,559 393 198 30 9 2,188
40–44 2,895 801 390 75 25 4,188
45–49 4,104 1,181 554 91 35 5,965
50–54 5,198 1,488 687 94 40 7,508
55–59 4,483 1,436 684 79 27 6,708
60–64 4,102 1,436 596 81 21 6,237
65–69 3,723 1,300 514 55 19 5,610
70–74 3,551 1,222 445 45 21 5,285
75–79 2,953 997 379 38 10 4,377
80–84 2,019 619 245 21 10 2,914
85+ 1,711 540 231 21 5 2,508
All ages 37,188 11,616 5,028 645 232 54,709
Ages 50–69 17,506 5,660 2,482 309 107 26,063
Source: AIHW National Cancer Statistics Clearing House. 
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Table 48: Age-specific and age-standardised incidence rates for breast cancer in women by region, 
1997–2001 
Age group Major cities Inner regional Outer regional Remote Very remote Australia
0–4 0.0 0.0 0.0 0.0 0.0 0.0
5–9 0.0 0.0 0.0 0.0 0.0 0.0
10–14 0.0 0.0 0.0 0.0 0.0 0.0
15–19 0.2 0.3 0.3 0.0 0.0 0.2
20–24 1.8 1.7 0.6 0.0 0.0 1.6
25–29 7.1 6.3 6.5 6.7 7.9 6.9
30–34 26.7 23.3 22.2 15.9 17.0 25.3
35–39 62.2 51.3 50.7 44.5 26.5 58.2
40–44 122.1 106.5 104.9 129.0 92.4 116.9
45–49 184.6 171.8 165.4 182.1 148.7 179.7
50–54 260.6 241.2 225.7 214.6 208.8 252.0
55–59 302.3 288.3 276.0 234.5 189.6 294.6
60–64 331.4 326.8 281.4 314.0 208.9 324.0
65–69 330.8 322.8 280.9 262.8 242.5 322.5
70–74 323.4 324.3 270.8 277.0 371.4 318.1
75–79 316.7 325.2 290.1 303.0 268.5 315.8
80–84 320.7 299.4 274.7 244.8 367.6 311.1
85+ 303.4 302.2 296.3 272.9 220.2 301.9
All ages        
Crude rate 117.0 117.8 103.0 84.8 56.8 114.7
ASR(A) 117.2 111.3 102.3 101.9 91.2 114.1
95% CI 116.0–118.4 109.3–113.4 99.5–105.2 94.1–110.2 79.2–104.3 113.1–115.0
Ages 50–69        
Crude rate 299.7 289.2 262.0 248.7 208.7 292.2
ASR(A) 299.4 286.7 260.9 249.9 209.8 291.4
95% CI 295.0–303.9 279.3–294.3 250.7–271.4 222.8–279.4 171.0–253.0 287.9–295.0
Note: Rates are the number of cases of invasive cancers per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
Source: AIHW National Cancer Statistics Clearing House. 
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Indicator 7b: Incidence of ductal carcinoma in situ  
Table 49: Number of new cases of ductal carcinoma in situ by age, states and territories,  
1996–2001 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
0–19 0 0 1 0 0 0 0 0 1
20–29 10 9 1 2 2 0 1 0 25
30–39 96 65 46 30 11 5 4 2 259
40–49 510 318 222 157 88 23 39 4 1361
50–59 723 559 363 277 204 62 44 8 2240
60–69 556 460 290 209 139 41 22 3 1720
70+ years 466 281 224 115 71 19 15 0 1191
All ages 2,361 1,692 1,147 790 515 150 125 17 6,797
Ages 50–69 1,279 1,019 653 486 343 103 66 11 3,960
Source: AIHW National Cancer Statistics Clearing House. 
 
Table 50: Age-specific and age-standardised rates of ductal carcinoma in situ, states and  
territories, 1996–2001 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
0–19 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
20–29 0.4 0.4 0.1 0.2 0.3 0.0 0.6 0.0 0.3
30–39 3.2 2.9 2.9 3.5 1.6 2.4 2.6 2.0 2.9
40–49 18.5 15.6 14.7 19.1 13.3 11.1 26.0 5.1 16.6
50–59 34.6 36.4 32.0 47.7 39.9 38.8 42.7 17.8 36.4
60–69 36.2 40.9 38.4 53.6 36.6 34.9 40.7 16.9 39.3
70+ years 22.9 18.9 23.6 24.5 13.1 12.3 25.3 0.0 20.9
All ages              
Crude rate 12.2 11.9 11.0 14.4 11.4 10.4 13.2 3.1 11.9
ASR(A) 12.3 12.0 11.5 15.4 11.0 10.4 14.8 4.5 12.2
95% CI 11.8–12.8 11.4–12.6 10.8–12.2 14.3–16.5 10.1–12.0 8.8–12.2 12.3–17.7 2.5–7.3 11.9–12.5
Ages 50–69              
Crude rate 35.3 38.3 34.5 50.1 38.5 37.2 42.0 17.5 37.6
ASR(A) 35.3 38.2 34.5 50.0 38.6 37.3 41.9 17.4 37.5
95% CI 32.0–38.6 34.3–42.1 30.2–39.1 43.0–57.6 32.3–45.4 26.5–49.7 25.6–61.5 2.1–41.6 35.6–39.5
Note: Rates are the number of cases of DCIS per 100,000 women and age-standardised to the Australian population at 30 June 2001. 
Source: AIHW National Cancer Statistics Clearing House. 
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Indicator 8: Mortality 
Table 51: Number of deaths from breast cancer in women, Australia, 1988–2002 
Age 
group 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
0–4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5–9 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
10–14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
20–24 0 1 0 2 1 0 1 1 0 1 2 2 1 1 0
25–29 5 7 6 12 4 2 2 5 9 6 7 6 5 2 4
30–34 26 34 26 25 33 39 19 25 28 37 28 20 23 21 24
35–39 66 67 63 79 79 73 87 57 90 84 68 59 66 63 71
40–44 120 137 149 150 136 116 139 120 136 135 128 141 122 126 112
45–49 152 170 168 177 196 202 211 207 189 211 207 203 187 185 173
50–54 202 212 228 232 212 225 239 221 230 271 265 247 255 262 295
55–59 238 217 215 227 219 252 249 248 240 236 227 260 257 253 289
60–64 291 287 282 258 236 276 262 268 258 239 255 263 239 228 273
65–69 290 297 328 306 272 316 290 317 289 284 252 212 216 242 256
70–74 251 251 258 305 287 264 308 288 296 297 268 288 287 315 245
75–79 254 261 254 249 254 298 274 281 279 291 300 274 281 289 312
80–84 184 205 205 211 213 257 250 259 252 244 236 232 237 273 277
85+ 222 238 219 229 247 268 271 280 273 273 314 298 335 325 367
All 
ages 2,301 2,384 2,401 2,462 2,389 2,589 2,602 2,577 2,569 2,609 2,557 2,505 2,511 2,585 2,698
Ages 
50–69 1,021 1,013 1,053 1,023 939 1,069 1,040 1,054 1,017 1,030 999 982 967 985 1,113
Source: AIHW National Mortality Database. 
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Table 52: Age-specific and age-standardised mortality rates for breast cancer in women, Australia, 
1988–2002 
Age 
group 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
0–4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
5–9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
10–14 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
15–19 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
20–24 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.2 0.2 0.0
25–29 0.7 1.0 0.8 1.7 0.6 0.3 0.3 0.7 1.3 0.8 1.0 0.8 0.7 0.3 0.6
30–34 3.9 5.0 3.7 3.5 4.6 5.3 2.6 3.4 3.9 5.2 3.9 2.8 3.2 2.8 3.2
35–39 10.4 10.4 9.6 11.9 11.7 10.6 12.5 8.0 12.3 11.3 9.0 7.8 8.7 8.4 9.6
40–44 21.1 23.0 24.1 23.5 21.2 17.9 21.2 18.0 20.0 19.5 18.2 19.7 16.7 16.9 14.7
45–49 34.9 37.3 35.1 35.2 36.4 35.3 35.4 33.6 29.5 32.8 31.7 30.5 27.7 27.1 25.0
50–54 53.5 54.5 56.9 56.2 50.0 51.8 52.8 46.4 46.2 50.4 46.3 41.3 40.9 40.4 45.4
55–59 65.5 60.1 59.9 63.3 59.8 67.1 64.6 62.7 58.9 56.0 52.4 57.4 54.3 51.0 54.0
60–64 78.6 77.4 76.1 69.7 64.6 76.8 73.4 75.1 72.3 65.7 68.5 68.4 60.2 55.9 65.0
65–69 88.1 86.6 94.1 87.1 77.1 88.9 81.8 89.5 81.5 80.6 72.2 61.3 62.6 69.8 72.0
70–74 93.8 94.4 95.3 108.1 98.1 87.0 97.1 89.2 90.5 90.4 80.9 86.4 86.0 94.1 73.6
75–79 123.4 121.5 115.1 110.4 110.9 129.5 120.3 120.4 114.4 113.5 111.6 97.6 97.7 99.0 105.9
80–84 142.6 153.2 147.1 145.1 140.6 162.4 149.5 150.2 142.7 135.7 129.6 126.7 124.7 135.3 131.0
85+ 222.4 230.6 207.4 208.1 213.6 219.9 212.5 208.4 192.8 182.8 200.3 179.4 191.3 177.3 192.6
All ages                      
Crude 
rate 27.8 28.3 28.1 28.4 27.2 29.2 29.0 28.4 27.9 28.0 27.2 26.3 26.0 26.4 27.3
ASR(A) 30.5 30.8 30.4 30.5 28.9 30.5 30.0 28.9 28.1 27.8 26.5 25.4 24.7 24.7 25.1
Ages 50–69                     
Crude 
rate 70.9 69.2 71.2 68.5 62.2 70.1 67.1 66.6 62.9 61.5 57.8 55.1 52.6 51.9 56.8
ASR(A) 68.3 66.7 68.5 66.5 60.6 67.9 65.5 64.6 61.5 60.6 57.3 55.0 52.5 51.8 56.7
Note: Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 
2001. 
Source: AIHW National Mortality Database. 
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Table 53: Number of deaths from breast cancer in women by age, states and territories, 1999–2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
0–4 0 0 0 0 0 0 0 0 0
5–9 0 0 0 0 0 0 0 0 0
10–14 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 0
20–24 1 1 1 1 0 0 0 0 4
25–29 4 8 2 2 1 0 0 0 17
30–34 34 17 18 9 5 2 1 2 88
35–39 75 81 43 20 25 9 4 2 259
40–44 148 127 96 52 55 14 4 5 501
45–49 228 201 137 69 67 23 12 11 748
50–54 311 283 213 98 93 34 17 10 1,059
55–59 368 271 184 95 90 26 16 9 1,059
60–64 351 267 159 80 92 31 17 6 1,003
65–69 347 211 133 85 98 31 17 4 926
70–74 376 311 202 104 93 26 19 4 1,135
75–79 394 339 187 91 96 37 11 1 1,156
80–84 352 284 165 76 96 32 11 3 1,019
85+ 430 371 208 123 138 40 14 1 1,325
All ages 3,419 2,772 1,748 905 949 305 143 58 10,299
Ages 50–69 1,377 1,032 689 358 373 122 67 29 4,047
Note: State refers to the state of usual residence. 
Source: AIHW National Mortality Database. 
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Table 54: Age-specific and age-standardised mortality rates for breast cancer in women, states and 
territories, 1999–2002 
Age group NSW Vic Qld WA SA Tas ACT NT Australia
0–4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
5–9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
10–14 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
15–19 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
20–24 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.2
25–29 0.4 1.1 0.4 0.7 0.5 0.0 0.0 0.0 0.6
30–34 3.5 2.3 3.3 3.2 2.3 3.1 2.0 5.6 3.0
35–39 7.4 10.8 7.7 6.7 10.9 12.6 7.8 6.1 8.6
40–44 14.9 17.4 17.5 17.6 23.8 19.1 7.8 17.1 17.0
45–49 25.2 30.0 27.1 25.1 30.8 33.8 24.4 42.8 27.5
50–54 37.1 45.3 45.1 39.9 44.9 53.5 37.2 47.6 42.0
55–59 55.3 55.9 50.1 52.0 55.6 51.0 51.6 67.6 54.1
60–64 63.3 65.6 54.8 53.7 68.0 72.0 77.8 73.9 62.3
65–69 71.0 58.8 55.1 68.2 81.3 83.2 101.2 79.0 66.5
70–74 79.4 89.9 89.0 92.2 76.4 74.0 127.4 112.0 85.0
75–79 95.9 112.8 96.8 96.6 87.4 119.5 84.3 42.7 100.1
80–84 125.0 141.2 123.6 119.4 128.2 146.4 133.0 195.7 129.6
85+ 171.1 196.9 176.6 199.7 199.5 209.8 209.0 85.0 185.3
All ages              
Crude rate 26.0 28.6 24.2 24.0 31.1 31.9 22.3 15.6 26.5
ASR(A) 23.9 26.4 24.0 24.3 26.4 28.2 26.6 27.1 25.0
95% CI 23.1–24.8 25.4–27.4 22.9–25.2 22.8–26.0 24.7–28.2 25.1–31.6 22.4–31.4 19.5–36.3 24.5–25.5
Ages 50–69              
Crude rate 54.1 55.0 50.2 51.0 59.7 62.6 58.1 61.0 54.1
ASR(A) 53.6 54.9 50.3 51.1 59.2 62.1 61.2 64.2 54.0
95% CI 50.8–56.5 51.6–58.4 46.6–54.2 46.0–56.7 53.3–65.5 51.6–74.2 47.3–77.9 42.1–93.3 52.3–55.7
Notes 
1. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 
2001. 
2. State refers to the state of usual residence. 
Source: AIHW National Mortality Database. 
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Table 55: Number of deaths from breast cancer in women by age and region, 1998–2002 
Age group Major cities Inner regional Outer regional Remote Very remote Australia
0–4 0 0 0 0 0 0
5–9 0 0 0 0 0 0
10–14 0 0 0 0 0 0
15–19 0 0 0 0 0 0
20–24 3 2 0 0 0 6
25–29 18 5 1 0 0 24
30–34 69 24 19 2 2 116
35–39 222 67 28 6 4 327
40–44 382 149 79 12 7 629
45–49 637 209 93 10 5 955
50–54 863 296 145 15 5 1,324
55–59 867 261 134 17 7 1,286
60–64 819 282 137 15 7 1,258
65–69 803 240 115 12 8 1,178
70–74 928 315 137 15 7 1,403
75–79 972 330 141 13 0 1,456
80–84 862 275 107 9 3 1,255
85+ 1,087 372 163 13 4 1,639
All ages 8,533 2,827 1,299 139 58 12,856
Ages 50–69 3,352 1,079 531 58 26 5,046
Note: Regions have been defined according to the ASGC Remoteness Areas classification. 
Source: AIHW National Mortality Database. 
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Table 56: Age-specific and age-standardised mortality rates for breast cancer in women by region, 
1998–2002 
Age group Major cities Inner regional Outer regional Remote Very remote Australia
0–4 0.0 0.0 0.0 0.0 0.0 0.0
5–9 0.0 0.0 0.0 0.0 0.0 0.0
10–14 0.0 0.0 0.0 0.0 0.0 0.0
15–19 0.0 0.0 0.0 0.0 0.0 0.0
20–24 0.1 0.4 0.2 0.0 0.0 0.2
25–29 0.7 0.8 0.3 0.0 0.0 0.7
30–34 2.8 3.6 5.3 3.6 4.7 3.2
35–39 8.8 8.8 7.3 9.0 11.3 8.7
40–44 15.8 19.3 20.9 20.7 24.7 17.2
45–49 28.3 29.7 27.3 20.3 22.7 28.3
50–54 41.7 46.1 46.1 33.4 23.4 42.8
55–59 55.6 49.6 52.0 48.9 50.2 53.8
60–64 64.4 61.9 62.5 54.4 61.5 63.5
65–69 71.5 59.2 62.6 55.1 96.5 67.6
70–74 84.8 82.6 82.7 91.6 115.2 84.2
75–79 101.6 104.3 105.0 99.0 7.0 102.2
80–84 132.6 127.8 116.0 105.8 92.6 129.6
85+ 183.9 197.1 199.7 160.7 161.9 188.0
All ages         
Crude rate 26.5 28.3 26.4 18.3 14.0 26.6
ASR(A) 25.3 25.3 25.4 22.6 22.6 25.3
95% CI 24.8–25.9 24.4–26.3 24.0–26.8 18.9–26.7 16.8–29.5 24.8–25.7
Ages 50–69         
Crude rate 55.7 53.1 54.5 45.6 49.1 54.8
ASR(A) 55.6 52.8 54.1 45.9 51.8 54.6
95% CI 53.8–57.5 49.6–56.0 49.6–59.0 34.9–59.3 33.8–75.9 53.1–56.1
Notes 
1. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population at 30 June 
2001. 
2. The Australian Standard Geographical Classification (ASGC) was used to create the above categories (ABS 2001). 
Source: AIHW National Mortality Database. 
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Table 57: Number of deaths from breast cancer in women by age and Indigenous status,  
Queensland, Western Australia, South Australia, Northern Territory, 1998–2002 
Age group Indigenous Non–Indigenous Australia 
0–4 0 0 0 
5–9 0 0 0 
10–14 0 0 0 
15–19 0 0 0 
20–24 0 2 6 
25–29 1 8 24 
30–34 3 40 116 
35–39 4 115 327 
40–44 11 240 629 
45–49 8 340 955 
50–54 7 499 1,324 
55–59 4 452 1,286 
60–64 6 429 1,258 
65–69 5 378 1,178 
70–74 7 465 1,403 
75+ 12 1,479 4,350 
All ages 68 4,447 12,856 
Ages 50–69 22 1,758 5,046 
Notes 
1. Only Queensland, Western Australia, South Australia, and the Northern Territory have Indigenous death registration data  
considered to be of a publishable standard; therefore data from these jurisdictions only are included in the analysis by  
Indigenous status.  
2. ‘Australia’ includes all states and territories of Australia. 
3. Deaths in the ‘not stated’ category are included in the column for all women, but they are not included in the other columns.  
Source: AIHW National Mortality Database. 
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Table 58: Age-standardised and age-specific mortality rates for breast cancer in 
women by Indigenous status, Queensland, Western Australia, South Australia,  
Northern Territory, 1998–2002 
Age group Indigenous Non-Indigenous Australia 
0–4 0.0 0.0 0.0 
5–9 0.0 0.0 0.0 
10–14 0.0 0.0 0.0 
15–19 0.0 0.0 0.0 
20–24 0.0 0.2 0.2 
25–29 2.0 0.6 0.7 
30–34 6.5 3.1 3.2 
35–39 10.1 8.5 8.7 
40–44 34.6 18.0 17.2 
45–49 31.7 27.4 28.3 
50–54 37.1 43.8 42.8 
55–59 30.4 51.9 53.8 
60–64 59.7 60.9 63.5 
65–69 71.7 62.3 67.6 
70–74 150.5 81.0 84.2 
75+ 184.6 131.2 133.3 
All ages     
Crude rate 11.8 25.7 26.6 
ASR(A) 30.9 24.8 25.4 
95% CI 23.1–40.4 24.1–25.6 25.0–25.9 
Ages 50–69     
Crude rate 44.9 53.0 54.8 
ASR(A) 46.4 53.0 54.6 
95% CI 28.9–70.5 50.5–55.5 53.1–56.1 
Notes 
1. Only Queensland, Western Australia, South Australia, and the Northern Territory have Indigenous death registration data 
considered to be of a publishable standard; therefore data from these jurisdictions only are included in the analysis by  
Indigenous status.  
2. ‘Australia’ includes all states and territories of Australia. 
3. Rates are the number of deaths from breast cancer per 100,000 women and age-standardised to the Australian population  
at 30 June 2001. 
4. Deaths in the ‘not stated’ category are included in the column for all women, but they are not included in the other columns.  
Source: AIHW National Mortality Database. 
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Appendix A: Data and statistical 
issues 
Data sources 
Multiple data sources were analysed to produce this report. These are summarised in  
Table A1. All data used in this report are based on calendar years. 
Table A1: Sources for data presented in this report 
Indicator Description Data source 
1 Participation BreastScreen Australia state and territory services 
2 Cancer detection BreastScreen Australia state and territory services 
3 Sensitivity BreastScreen Australia state and territory services 
4 DCIS detection BreastScreen Australia state and territory services 
5 Recall to assessment BreastScreen Australia state and territory services 
6 Rescreening BreastScreen Australia state and territory services 
7 Incidence (ICD 174) National Cancer Statistics Clearing House, AIHW 
8 Mortality (ICD 174) National Mortality Database, AIHW 
 
Population data 
The ABS estimated resident population (ERP) data were used to calculate screening 
participation, and cancer incidence and mortality rates.  
Participation rates were calculated using the average of the 2001 and 2002 estimated resident 
female populations. The only exceptions to this were participation rates by socioeconomic 
status, by language spoken at home and by Indigenous status.  
As the ABS does not calculate ERP by socioeconomic status or language spoken at home 
alternative methods were used to calculate the denominators for these rates. In the case of 
language spoken at home, the denominator was calculated by applying the age-specific 
distribution from the language question in the 2001 national population census to the 
relevant age-specific ERP counts. The denominator for rates based on socioeconomic status 
was calculated by applying an ABS concordance between statistical local area (SLA) and 
socioeconomic status to the relevant ERP by SLA counts. 
The most recent direct count of the Aboriginal and Torres Strait Islander population was 
carried out in the 2001 census. However, the ABS has released estimates of Aboriginal and 
Torres Strait Islander population for more recent years. The average of the direct count for 
2001 and the estimated population for 2002 was used as the denominator for Indigenous 
participation rates.  
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Mortality data 
Mortality data in this report are given for 1988 to 2002. During this time, changes have been 
made to the coding and processing of mortality data that affect the comparability of the data. 
Data holdings for 1987–1996 were manually coded using the ninth revision of the 
International Classification of Diseases (ICD-9). Data holdings for 1997 onwards have been 
coded using ICD-10. These data were coded using an automated system with slightly 
different coding rules. 
The change to the coding and processing of mortality data has introduced a break in the data 
time series. The ABS has developed comparability factors, which are applied to the pre-1997 
data, so that a single time series may still be derived (ABS 2002). For breast cancer, the 
comparability factor is close to one. 
The application of a comparability factor causes the number of deaths before 1997 to be non-
integer. Rounding has been used to put the number of deaths into whole numbers. 
Statistical analysis of BreastScreen monitoring 
indicators 
Crude rates 
A crude rate is defined as the number of events over a specified period (for example, a year) 
divided by the total population at risk of the event. For example, a crude cancer incidence 
rate is defined as the number of new cases of cancer in a specified period divided by the 
population at risk.  
Age-specific rates 
An age-specific rate is defined as the number of events for a specified age group over a 
specified period (for example, a year) divided by the total population at risk of the event in 
that age group. Age-specific rates in this report were calculated by dividing the number of 
deaths, cancer cases or women participating in the screening programs in each specified age 
group by the corresponding population in the same age group.  
Age-standardised rates (ASR) 
Age-standardised rates enable comparisons to be made between populations which have 
different age structures. This publication uses direct standardisation, in which the age-
specific rates are multiplied by a constant population. This effectively removes the influence 
of the age structure on the summary rate.  
As the National Health Data Dictionary recommends the use of the 2001 Australian total 
estimated resident population as the standard population for health statistics, this 
population has been used for age-standardising mortality, incidence and participation rates. 
For statistics based on the population of women screened—that is, cancer detection rates, 
interval cancer rates and program sensitivity—rates are standardised to the 1998 population 
of women screened by BreastScreen Australia.  
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The method used for all these calculations consists of three steps: 
Step 1: Calculate the age-specific rate for each age group. 
Step 2: Calculate the expected number of cases in each five-year age group by 
multiplying the age-specific rates by the corresponding standard population and 
dividing by the appropriate factor (that is, 100,000 for mortality and incidence rates, 
10,000 for cancer detection and sensitivity rates, and 100 for the participation rate). 
Step 3: Sum the expected number of cases in each age group, divide by the total of the 
standard population and multiply by the appropriate factor (that is, 100,000 for 
mortality and incidence rates, 10,000 for cancer detection and sensitivity rates, and 
100 for the participation rate). This gives the age-standardised rate. 
Rate denominators 
Death rates and cancer incidence rates are expressed in this report as annual rates per 
100,000 population. Rates for cancer detection are calculated per 10,000 women screened. 
Screening participation rates are expressed as a percentage of the eligible population. 
Rescreen and recall-to-assessment rates are expressed as a percentage of women screened. 
Confidence intervals (CI) 
The 95% confidence intervals in this report were calculated using a method developed by 
Dobson et al. (1991). This method calculates approximate confidence intervals for a weighted 
sum of Poisson parameters. 
The confidence intervals are used to provide an approximate indication of the differences 
between rates. Where the confidence intervals of two rates do not overlap, the corresponding 
rates are statistically significantly different from each other. This is used to compare 
individual stratified rates with the all-Australia rate. To be truly rigorous, such a comparison 
should be between a given rate and the rate calculated from the all-Australia data excluding 
the data underlying the specific rate in the comparison. Presentation of such a comparison in 
this report would, however, be unnecessarily complex. The approximate comparisons 
presented might understate the statistical significance of some differences, but they are 
sufficiently accurate for the purposes of this report.  
As with all statistical comparisons, care should be exercised in interpreting the results of the 
comparison. If two rates are statistically significantly different from each other, this means 
that the difference is unlikely to have arisen by chance. Judgement should, however, be 
exercised in deciding whether or not the difference is of any practical significance. 
Stratification variables 
The data in this report are presented stratified by the age of the women at the time of 
screening (for the screening data), at the time of diagnosis (for the cancer incidence data) or 
at the time of death (for the cancer mortality data). A number of stratification variables apply 
to some or all of the data presented: 
• state or territory 
• geographic location 
• socioeconomic status 
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• Indigenous status 
• main language spoken at home 
• tumour size 
• screening round. 
State or territory 
The state or territory reported is the one where screening took place (for the screening data) 
or where the diagnosis was made (for the cancer incidence data) or the place of usual 
residence for the cancer mortality data.  
This means that it is possible for a woman to be double-counted in the screening data. If she 
was screened in one jurisdiction and then screened again less than two years later in another 
jurisdiction, both screens may be included in the participation rate. This should, however, 
have a negligible effect on the reported participation rates. 
Geographic location 
In all previous reports, analysis of participation, incidence and mortality data by geographic 
region used the Rural, Remote and Metropolitan Areas (RRMA) classification. This 
classification was developed in 1994 by the then Department of Primary Industries and 
Energy and the then Department of Human Services and Health. It allows geographic 
regions to be classified into seven zones: two metropolitan, three rural and two remote.  
This report uses a more recent geographic classification in place of RRMA. The new system, 
known as the Australian Standard Geographical Classification (ASGC), groups geographic 
areas into five classes. These classes are based on Census Collection Districts (CDs) and 
defined using the Accessibility/Remoteness Index for Australia (ARIA). ARIA is a measure 
of the remoteness of a location from the services provided by large towns or cities. A higher 
ARIA score denotes a more remote location. The five classes of the ASGC Remoteness 
classification, along with a sixth ‘Migratory’ class, are listed in Table A2. 
Table A2: The Remoteness Areas for the ASGC Remoteness Classification 
Region Collection Districts within region 
Major cities of Australia CDs with an average ARIA index value of 0 to 0.2 
Inner regional Australia CDs with an average ARIA index value greater than 0.2 and less than or equal to 2.4 
Outer regional Australia CDs with an average ARIA index value greater than 2.4 and less than or equal to 5.92 
Remote Australia CDs with an average ARIA index value greater than 5.92 and less than or equal to 10.53 
Very remote Australia CDs with an average ARIA index value greater than 10.53  
Migratory Areas composed of off-shore, shipping and migratory CDs 
Source: ABS 2001. 
The ASGC Remoteness classification is not directly comparable to the RRMA classification. 
Accessibility is judged purely on distance to one of the major urban centres. For example, the 
ASGC Remoteness classification allocates Hobart to its second group (Inner regional 
Australia) and Darwin to its third group (Outer regional Australia), whereas the RRMA 
classification grouped them together with the other capital cities. 
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Socioeconomic status 
Socioeconomic status was coded according to the Index of Relative Socio-economic 
Disadvantage (IRSD). The IRSD is one of the socioeconomic indexes for areas (SEIFA 
indexes) developed by the ABS to categorise geographic areas according to their social and 
economic characteristics.  
It is important to note that the IRSD relates to the average disadvantage of all people living 
in a geographic area. Hence any variability between groups based on the IRSD will probably 
be smaller than if the variability had been measured between individuals.  
Indigenous status 
The BreastScreen Australia Data Dictionary (AIHW & DoHA forthcoming) specifies that 
Indigenous status should be coded as: 
• Aboriginal 
• Torres Strait Islander 
• both Aboriginal and Torres Strait Islander 
• not Indigenous or 
• not stated. 
For the purposes of this report these categories were amalgamated and the data stratified 
into three categories: 
• Indigenous 
• not Indigenous or 
• not stated. 
Main language spoken at home 
The BreastScreen Australia Data Dictionary (AIHW & DoHA forthcoming) recommends that 
main language spoken at home be coded according to the four digit ABS Australian 
Standard Classification of Languages, 1998 (ABS cat. no. 1267.0). This report has collapsed 
the classification into the simple dichotomy of ‘English’ and ‘Other language’.  
Although this stratification is reported as ‘main language spoken at home’, practice varies 
between the jurisdictions as to how this information is collected. In some jurisdictions there 
may thus be some lack of comparability with the BreastScreen Data Dictionary definition of 
‘main language’. 
In addition, some jurisdictions do not use the ‘Not stated’ classification. If main language 
spoken at home is not given, it is set to a default value. The default used is not the same for 
all jurisdictions. This means that the analysis based upon main language spoken at home 
should be interpreted with caution. 
Tumour size 
Tumour size is the size in millimetres of the malignant lesion, and applies to invasive cancers 
only. For more details about this stratification, see the definition given in the BreastScreen 
Australia Data Dictionary (AIHW & DoHA forthcoming). 
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Screening round 
The BreastScreen Australia Data Dictionary distinguishes between a woman’s screening 
round in the national program and her round in the state or territory program. Round in the 
national program is used for this stratification in this report. However, it is not always 
possible to determine round in the national program, so for some women this stratification 
has been collected as round number in the state or territory program.  
BreastScreen Australia Data Dictionary 
A data dictionary has been developed for the BreastScreen Australia Program (AIHW & 
DoHA forthcoming). Summary definitions of key concepts and terminology used in this 
report are given in the glossary. More detailed definitions and explanations may be found in 
the data dictionary. 
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Abbreviations 
AACR: Australasian Association of Cancer Registries 
ABS: Australian Bureau of Statistics 
ACT: Australian Capital Territory 
AIHW: Australian Institute of Health and Welfare 
AHMAC: Australian Health Ministers Advisory Council 
ARIA: Accessibility/Remoteness Index for Australia 
ASGC: Australian Standard Geographical Classification 
ASR: age-standardised rate 
ASR(A): age-standardised rate, standardised to the Australian standard population 
BSANAC: BreastScreen Australia National Advisory Committee 
CD: Census Collection District 
CI: confidence interval (see glossary) 
DoHA: Australian Government Department of Health and Ageing 
DCIS: ductal carcinoma in situ 
ERP: estimated resident population 
ICD: International Classification of Diseases 
IRSD: Index of Relative Socio-economic Disadvantage 
NBCC: National Breast Cancer Centre 
NQMC: National Quality Management Committee 
NSW: New South Wales 
NT: Northern Territory 
Qld: Queensland 
RRMA: Rural, Remote and Metropolitan Areas classification 
SA: South Australia 
SES: socioeconomic status 
SLA: statistical local area 
Tas: Tasmania 
Vic: Victoria 
WA: Western Australia 
WHO: World Health Organization 
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Glossary 
Administrative databases: observations about events that are routinely recorded or required 
by law to be recorded. Such events include births, deaths, hospital separations and cancer 
incidence. Administrative databases include the National Mortality Database, the National 
Hospital Morbidity Database and the National Cancer Statistics Clearing House Database. 
Age-specific rate: a rate for a specific age group. The numerator and denominator relate to 
the same age group. 
Age-standardised rate: weighted average of age-specific rates according to a standard 
distribution of the population by age to eliminate the effect of different age distributions and 
thus facilitate valid comparison of groups with differing age compositions. 
Assessment: further investigation of a mammographic abnormality or symptom reported at 
screening. This includes women who choose assessment outside the Program.  
Benign: not cancerous. 
Cancer (malignant neoplasm): a term used to describe one of several diseases that result 
when the process of cell division, by which tissues normally grow and renew themselves, 
becomes uncontrolled and leads to the development of malignant cells. These cancer cells 
multiply in an uncoordinated way, independently of normal growth control mechanisms, to 
form a tumour. The tumour can expand locally by invasion or systemically by metastasis via 
the lymphatic or vascular systems. If left untreated, most malignant tumours eventually 
result in death. 
Cancer death: a death where the underlying cause is indicated as cancer. People with cancer 
who died of other causes are not counted in the death statistics in this publication. 
Confidence interval: a range determined by variability in data, within which there is a 
specified (usually 95%) chance that the true value of a calculated parameter (for example, 
relative risk) lies.  
Core biopsy: removal of a cylindrical sample of breast tissue under a local or general 
anaesthetic through a needle for microscopic examination. 
Data: refers to the building blocks of health information, including observations from 
administrative databases and health survey data sets. 
Ductal carcinoma in situ: a non-invasive tumour of the mammary gland (breast) arising 
from cells lining the ducts. 
Early review: a woman is screened but not cleared for routine rescreening and instead is 
referred for further assessment within 6 to 12 months of the index screen. 
Epidemiology: the quantitative study of the distribution and determinants of health-related 
states and events in populations and the application of this study to the control of health 
problems. 
False negative: means that the test has incorrectly observed that the disease is not present. 
False positive: means that the test has incorrectly observed that the disease is present. 
Film reading: viewing of a radiographic depiction of the breast (a mammogram) to 
determine the presence or absence of an abnormality indicative of a tumour. 
Fine needle aspiration biopsy: the sampling of cells from breast tissue for examination by a 
pathologist. 
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First screening round: see Screening round. 
Incidence: see New cancer case.  
Index screening year: the year for which the interval cancer rate and the program sensitivity 
rate are determined. 
Index screens: all screening examinations performed within the index screening year. 
Indicators: observations about data that have been analysed to provide a means of 
comparing measures of health within and between population groups. 
Indigenous: a person of Aboriginal and/or Torres Strait Islander descent who identifies as 
an Aboriginal and/or Torres Strait Islander person and is accepted as such by the 
community with which he or she is associated. 
Information: observations about data that have been analysed to provide a means of 
comparing measures of health within and between population groups. 
International Classification of Diseases: WHO’s internationally accepted classification of 
death and disease. The tenth revision (ICD-10) is currently in use.  
Interval cancer—invasive (as defined for national reporting purposes by Kavanagh et al. 
(1999), with minor changes pending endorsement by the National Advisory Committee): 
• an invasive breast cancer diagnosed after completion of a negative screening episode and 
before the next screening examination (within 24 months from the date of the previous 
screen) 
• a case of invasive breast cancer that is diagnosed at early review or in the interval 
between assessment and early review, where the recommendation for early review is six 
months or more from the screening date 
• breast cancer diagnosed in a woman by BreastScreen Australia within 24 months of a 
negative screen (early rescreen) if the woman presents with a breast lump and/or clear 
or blood-stained nipple discharge in the breast in which the breast cancer was diagnosed, 
or 
• an invasive breast cancer diagnosed between six and 24 months after a recommendation 
for assessment is made and a woman fails to attend assessment.  
Invasive cancer: a tumour whose cells have invaded healthy or normal tissue. 
Lymph node: masses of lymphatic tissue, often bean-shaped, that produce lymphocytes and 
through which lymph filters. These are located throughout the body. 
Mammogram: a radiographic depiction of the breast. 
Metastasis: the process by which a disease is transferred from one part of the body to 
another—for example, via the lymphatic system or the bloodstream. 
Mortality: see Cancer death. 
New cancer case: a person who has a new cancer diagnosed for the first time. One person 
can have more than one cancer and therefore may be counted twice in incidence statistics if it 
is decided that the two cancers are not of the same origin. This decision is based on a series 
of principles set out in more detail in a publication by Jensen et al. (1991). 
Next scheduled screening examination: 24 months after previous screen unless the woman 
is recommended for annual rescreening, when the next scheduled screening examination is 
12 months. 
Population estimates: official population numbers compiled by the Australian Bureau of 
Statistics at both state and territory and statistical local area levels by age and sex, as at 30 
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June each year. These estimates allow comparisons to be made between geographic areas of 
differing population sizes and age structures. 
Prevalence: the number of instances of a specific disease or other condition in a given 
population at a designated time.  
Recruitment: strategies that aim to promote participation of women in the BreastScreen 
Australia Program through direct contact with women in the target age group and education 
of health practitioners and the general public. Women are encouraged to attend every two 
years. 
Rescreening: the next screening examination after the screening episode in the index 
screening year. 
Risk factor: an attribute or exposure that is associated with an increased probability of a 
specified outcome, such as the occurrence of a disease. Risk factors are not necessarily the 
causes of disease. 
Screening: the performance of tests on apparently well people in order to detect a medical 
condition at an earlier stage than would otherwise be the case. As a screening test is not 
intended to be diagnostic, so a person with a positive or suspicious result must be referred 
for diagnosis and treatment. 
Screening episode: includes screening examination and assessment. Early review within  
6 to 12 months of an initial screen is not considered part of the screening episode. 
Screening round: the first screening round is a woman’s first visit to a mammography 
screening service; a subsequent screening round means that she has been screened before. If 
she attends for the fourth screening round, she has been screened three times before. 
Screening round (first): a woman’s first visit to a BreastScreen Australia mammography 
screening service. 
Screening round (subsequent): a woman’s visit to a BreastScreen Australia mammography 
screening service when she has attended such a service before.  
Sensitivity: the proportion of people with a disease who have a positive test result for the 
disease.  
Significant difference: where rates are referred to as significantly different, or one rate is 
deemed significantly higher or lower than another, these differences are statistically 
significant. Rates are deemed statistically significantly different when their confidence 
intervals do not overlap, since their difference is greater than what could be explained by 
chance. See ‘confidence intervals’ in Appendix A for more information.  
Symptom: any evidence of disease apparent to the patient. For the purposes of this report, 
symptoms refer to a self-reported breast lump and/or blood-stained or watery nipple 
discharge. 
Ultrasound: diagnostic method based on the reflection of ultrasonic sound waves generated 
through scanning of, in this case, the breast. The reflections are viewed on a computer screen 
or photograph and checked for variations in images. 
Unit record file: observations containing person-specific records from health surveys and 
administrative databases that are unanalysed and not tabulated. This is the most basic form 
of data and cannot be accessed for general use without appropriate confidentiality measures 
being in place. 
Women-years at risk: all women screened in the index screening year who are resident in 
the state or territory in which they are screened who have not reported a personal history of 
breast cancer. 
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